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Introduction
During development, tissue differentiation relies on the es-
tablishment of specific patterns of gene expression, which is 
achieved by lineage-specific gene activation and silencing in 
multipotent stem cells and their progenies (Slack, 2008; Blan-
pain and Fuchs, 2014). The program of epidermal differentiation 
in mice begins at about embryonic day 9.5 (E9.5) and results 
in the formation of an epidermal barrier by E18.5 (Koster and 
Roop, 2007; Blanpain and Fuchs, 2009). The process of termi-
nal differentiation in epidermal cells is executed by sequential 
changes of gene expression in the keratin type I/II loci, followed 
by the onset of expression of the epidermal differentiation com-
plex genes encoding the essential components of the epidermal 
barrier (Fuchs, 2007). This program is governed by the coordi-
nated involvement of several transcription factors (p63, AP-1, 
Klf4, Arnt, etc.), signaling pathways (Wnt, Bmp, Hedgehog, 
EGF, Notch, FGF, etc.), and epigenetic regulators (DNA/his-
tone-modifying enzymes, Polycomb genes, higher order and 
ATP-dependent chromatin remodelers, and noncoding and 
microRNAs) that control expression of lineage-specific genes 
(Khavari et al., 2010; Botchkarev et al., 2012; Frye and Benitah, 
2012; Perdigoto et al., 2014).
Among these regulatory molecules, the p63 transcription 
factor serves as a master regulator of epidermal development and 
controls expression of a large number of distinct groups of genes 
(Viganò and Mantovani, 2007; Vanbokhoven et al., 2011; Botch-
karev and Flores, 2014; Kouwenhoven et al., 2015). p63 knockout 
(KO) mice fail to form stratified epithelium and express several 
epidermis-specific genes (Mills et al., 1999; Yang et al., 1999). In 
the epidermis, p63 regulates the expression of distinct chroma-
tin-remodeling factors, such as Satb1 and Brg1, which, in turn, 
control the establishment of specific nuclear positioning and con-
formation of the epidermal differentiation complex locus required 
for full activation of keratinocyte (KC)-specific genes during ter-
minal differentiation (Fessing et al., 2011; Mardaryev et al., 2014).
Epigenetic regulators exhibit both activating and repres-
sive effects on chromatin in KCs: the histone demethylase 
Jmjd3, ATP-dependent chromatin remodeler Brg1, and genome 
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organizer Satb1 promote terminal KC differentiation, whereas 
the DNA methyltransferase DNMT1, histone deacetylases 
HDAC1/2, and Polycomb components Bmi1 and Ezh1/2 stim-
ulate proliferation of the progenitor cells via repression of the 
genes encoding cell cycle inhibitors, as well as inhibiting pre-
mature activation of terminal differentiation–associated genes 
(Sen et al., 2008, 2010; Ezhkova et al., 2009; LeBoeuf et al., 
2010; Fessing et al., 2011; Mardaryev et al., 2014).
Polycomb chromatin-remodeling proteins form two com-
plexes (Polycomb repressive complex 1 and 2 or PRC1/2) that 
compact the chromatin and inhibit transcription by prevent-
ing binding of the transcription machinery to gene promoters 
(Simon and Kingston, 2013; Cheutin and Cavalli, 2014). Recent 
data reveal that binding of the noncanonical PRC1 complex 
containing histone demethylase KDM2B, PCGF1, and RING/
YY1-binding protein (RYBP) promotes basal ubiquitylation of 
the H2A at lysine 119 (H2AK119) at unmethylated CpG-rich 
DNA regions, which is sufficient to recruit the PRC2 complex 
(Blackledge et al., 2014; Cooper et al., 2014; Kalb et al., 2014). 
The PRC2 component Ezh1/Ezh2 histone methyltransferase 
promotes trimethylation of H3K27, followed by targeting of 
the Cbx proteins as a part of the canonical PRC1 complex to 
H3K27me3, which result in further increase of the H2AK119 
ubiquitylation catalyzed by the PRC1 component Ring1b 
(Simon and Kingston, 2013; Cheutin and Cavalli, 2014; Perdig-
oto et al., 2014; Schwartz and Pirrotta, 2014).
In the epidermis, the Polycomb components Bmi1, 
Ezh1/2, and Jarid2 stimulate proliferation of the progenitor 
cells via repression of the genes encoding cell cycle inhibitors, 
including the INK4A–INK4B locus, as well as inhibit prema-
ture activation of terminal differentiation–associated genes (Ez-
hkova et al., 2009; Mejetta et al., 2011). In addition, Ezh1/2 
restricts differentiation of the epidermal progenitor cells by re-
pressing the Sox2 gene, which, in turn, promotes Merkel cell–
specific differentiation (Bardot et al., 2013).
The Cbx4 gene belongs to the PRC1 family and has a 
chromodomain interacting with the H3K27me3 histone mark 
and mediating transcriptional repression together with the 
PRC2 complex (Li et al., 2007; Luis et al., 2011). Cbx4 also 
possesses SUMO E3 ligase activity that promotes sumoylation 
of other proteins, including DNA methyltransferase Dnmt3a, 
thus providing a link between Polycomb-mediated gene silenc-
ing and DNA methylation (Li et al., 2007). In normal human 
skin, the Cbx4 protein protects epithelial stem cells from senes-
cence through PRC-dependent repression of the Ink4a locus, as 
well as controls their differentiation through PRC-independent 
mechanisms (Luis et al., 2011). These data suggest Cbx4 as 
a critical determinant regulating the activity of stem cells and 
their progenies in the skin. However, its role in the control of 
epidermal development and in establishing tissue-specific gene 
expression patterns still remains unclear.
Here, we show that Cbx4 is a critical determinant regu-
lating the establishment and maintenance of the epidermal dif-
ferentiation program that represses nonepidermal lineage genes 
and controls cell proliferation/differentiation in the epidermis. 
We also show that Cbx4 serves as a direct p63 target and me-
diates its repressive effects on the expression of nonepidermal 
lineage genes and selected cell cycle inhibitor genes. These data 
illustrate how p63 transcription factor operates in concert with 
epigenetic regulator Cbx4 to establish and maintain the lin-
eage-specific program in differentiating cells and in governing 
epithelial differentiation/function.
Results
Cbx4 expression is increased in the 
epidermal KCs during the stratification 
stage of epidermal development
To perform the genome-wide analysis of transcriptomes in epi-
dermal progenitor cells during development, we used laser cap-
ture microdissection (LCM) and obtained RNA samples from 
the basal epidermal layer before and after the onset of epider-
mal stratification (E11.5 and E16.5, respectively), as well as 
postnatally at 1.5 d (P1.5) and 8 wk (P56, adult) as described 
previously (Sharov et al., 2006). Detailed analysis of the tran-
script levels of different Polycomb group genes revealed their 
dynamic expression during development of the mouse epider-
mis (Fig. S1 A and Table S1). Among the PRC1 genes, the 
Cbx4 transcript and protein levels were strongly increased in the 
basal KCs during the transition from single-layered epithelium 
to stratified squamous epidermis (E11.5 vs. E16.5; Fig. 1, A and 
B; Fig. S1 A; and Table S1). Consistent with previous observa-
tions (Ezhkova et al., 2009), the onset of epidermal stratification 
(E11.5–E16.5) was also characterized by the highest levels of 
the PRC2 component Ezh2 gene expressions in the basal KCs, 
followed by its decline at the later stages of epidermal differen-
tiation (E16.5–P1.5; Fig. S1 A and Table S1).
Interestingly, Cbx4 protein expression was even higher 
in differentiating suprabasal KCs, whereas significantly lower 
expression levels were seen in the dermal compartment of the 
skin (Fig. 1, B and D). In contrast to Cbx4, other PRC1 genes 
showed a less pronounced increase, or even a decrease, in their 
expression levels at the early stages of epidermal development 
(Fig. S1 A). As the epidermis fully matured (P1.5), basal pro-
genitor cells showed a decline in expression of most of the PRC1 
genes except Cbx7, Phc1, and Pcgf1 (Fig. S1 A and Table S1). 
Interestingly, Cbx4 expression levels also decreased in the basal 
KCs of adult skin compared with E16.5, but were still consid-
erably higher than at E11.5 (Fig. 1 C, Fig. S1 A, and Table S1).
Cbx4 controls KC proliferation 
and terminal differentiation in the 
developing epidermis
To uncover the role of Cbx4 in the epidermal progenitor cells 
during development, we used mice bearing an inactivation allele 
lacking the first two exons and a 0.9-kb upstream region of the 
Cbx4 gene disrupting functional Cbx4 protein synthesis (Liu et 
al., 2013). The Cbx4 homozygous KO mice were not viable and 
died within 1 h after birth because of some (not yet fully clear) 
developmental abnormalities, including thymic hypoplasia (Liu 
et al., 2013). Immunostaining analysis for Cbx4 confirmed the 
abolished protein expression in the skin of Cbx4KO compared 
with wild-type (WT) littermates (Fig. 1 B).
To explore the skin phenotype upon Cbx4 ablation, we per-
formed a histological assessment of the stratified skin epithelium at 
different developmental time points: E14.5, E16.5, and E18.5. At 
E14.5, Cbx4-null epidermis showed significantly reduced thick-
ness correlated with a decreased number of stratified cellular lay-
ers and significant reduction in the number of proliferating Ki67+ 
cells in the basal layer compared with WT controls (Fig. 1, E–H). 
Similar to E14.5, Cbx4-null epidermis remained significantly 
thinner and harbored fewer proliferating basal cells at E16.5, 
whereas such differences become insignificant at E18.5 (Fig. 1, 
E–H). At E16.5, the appearance of the senescence-associated 
marker γ-H2AX was seen in the epidermis of Cbx4KO mice, 
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whereas immunostaining for active caspase 3 showed a lack of 
any changes in the KC apoptosis between WT and Cbx4KO mice 
(Fig. S3, E and F). The reduced proliferation of E16.5 basal epi-
dermal KCs was associated with increased expression of the cell 
cycle inhibitor genes (senescence-linked Ink4a locus p16/p19 
and Cdkn1c/p57 gene; Fig. S3, A and B), which are well-known 
targets of the Polycomb proteins in several tissues, including the 
skin (Ezhkova et al., 2009; Luis et al., 2011).
As CBX4 was previously shown to prevent terminal dif-
ferentiation in human epidermal progenitor cells independently 
of its Polycomb-associated repressive function (Luis et al., 
2011), we explored the effect of Cbx4 ablation on the expres-
sion of early and late epidermal differentiation genes in the de-
veloping mouse epidermis. In the absence of Cbx4, cells of the 
embryonic ectoderm were able to acquire an epidermal fate and 
commence a differentiation program as indicated by positive 
K14 and K10 staining in the basal and suprabasal cells (Figs. 1 I 
and S4 A). However, Loricrin, a marker of terminally differ-
entiating KCs, was prematurely expressed in the suprabasal 
cells located just above the basal cells in the Cbx4-deficient 
epidermis at E14.5, whereas its expression was not detectable 
in WT epidermis at this stage (Figs. 1 J and S4 A). In E16.5 
WT embryos, the most superficial late suprabasal cells under-
went terminal differentiation and expressed the key components 
of the cornified cell envelope such as Loricrin, Involucrin, and 
Filaggrin (Figs. 1 J and S4 A). In contrast to WT mice, the pre-
mature onsets of Loricrin, Involucrin, and Filaggrin expression 
were seen in the early suprabasal cells in E16.5 Cbx4KO mice 
(Figs. 1 J and S4 A). Immunofluorescence data on the expres-
sion of the markers of terminally differentiated KCs were in 
concordance with quantitative real time–PCR (qRT-PCR) data 
showing the markedly elevated levels of the Lor, Inv, and Flg 
Figure 1. Cbx4KO mice show a decrease of cell proliferation and premature terminal differentiation in the developing epidermis. (A) Cbx4 transcript 
expression in epidermal KCs at E11.5, E16.5, and P1.5 (qRT-PCR; mean ± SD; n = 3). (B) Cbx4 immunofluorescence is not detected in the E11.5 epider-
mis. In comparison to E11.5, Cbx4 levels are increased in basal and suprabasal KCs at E16.5, as well as in postnatal (P56) skin (arrows). Cbx4KO mice 
show a lack of Cbx4 expression in the epidermis. Integrin-β4 (Itgb4) expression outlines the basement membrane of the epidermis. DAPI counterstain (blue) 
shows the nuclei. (C) Quantification of Cbx4+ cells in the epidermis at different developmental stages in WT mice and in Cbx4KO skin (mean ± SD). n = 3.  
(D) Quantification of Cbx4 total cell fluorescence in both epidermal and dermal skin compartments of WT mice at E16.5 (box plot with 5–95% confidential 
intervals; the whiskers show minimum and maximum values). n = 3. (E and F) Histomorphological analyses of the alkaline phosphatase/hematoxylin-stained 
skin showed a reduced epidermal thickness in Cbx4KO mice compared with WT mice at E14.5 and E16.5 (mean ± SD). n = 3. Dashed lines separate 
epidermis and dermis. (G and H) Immunofluorescence detection (H) and quantification (G) of Ki67+ cells (H, arrows) showed reduced cell proliferation in 
the Cbx4KO epidermis versus WT counterpart at E14.5 and E16.5 (box plot with 5–95% confidential intervals). n = 4. Integrin-β4 expression outlines the 
basement membrane of the epidermis. (I and J) Immunofluorescence detection of K14 and K10 (I) and late (J) differentiation markers revealed premature 
onset of the terminal differentiation in the Cbx4KO epidermis (dashed lines indicate the epidermal/dermal border). In Cbx4KO mice, Loricrin protein was 
detected as early as E14.5, before onset of terminal differentiation in WT mice (J). At E16.5, Loricrin and Filaggrin were detected in early suprabasal cells, 
whereas Involucrin expression was up-regulated already in the basal progenitor cells (arrows). Brackets and asterisks depict the positions of the spinous 
and granular epidermal layers, respectively. (K) Increase of the Lor, Ivl, and Flg mRNA levels in the LCM-captured basal epidermal cells of E16.5 Cbx4KO 
mice versus WT controls (mean ± SD). n = 3. ***, P < 0.001. Bars, 25 µm. ns, not significant.
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transcripts in the E16.5 epidermis of Cbx4KO mice versus WT 
controls (Fig.  1 K). Thus, Cbx4 suppresses the expression of 
terminal differentiation–associated genes in the basal progeni-
tor cells during murine epidermal development.
Cbx4 represses nonepidermal lineage genes 
in KCs during epidermal development
Next, we analyzed the distribution of H2AK119Ub and 
H3K27me3, two key histone modifications associated with 
Polycomb-mediated gene repression, in the epidermis of 
Cbx4KO mice. According to the model of Polycomb-mediated 
gene silencing, a basal level of H2AK119 ubiquitylation at un-
methylated CpG-rich DNA regions is maintained by noncanon-
ical PRC1 complexes lacking the Cbx proteins, whereas one 
of the Cbx family members serving as a part of the canonical 
PRC1 complex is only involved in the subsequent step in the 
Polycomb-mediated gene silencing and is required for bind-
ing to H3K27me3, followed by the Ring1b-mediated further 
increase of the H2AK119 ubiquitylation over its basal level 
(Simon and Kingston, 2013; Cheutin and Cavalli, 2014; Perdig-
oto et al., 2014; Schwartz and Pirrotta, 2014).
In contrast to WT mice, epidermal cells in E14.5 and 
E16.5 Cbx4KO mice showed a significantly decreased level of 
H2AK119ub1 expression, which we considered as a basal level 
(Fig. 2, A and B). However, the expression levels of H3K27me3 
were not changed in the epidermis of Cbx4KO mice compared 
with WT controls (Fig.  2, C and D). Also, expression of the 
histone methylase Kdm2b, a constituent of the noncanonical 
PRC1 complex (Schwartz and Pirrotta, 2014), was increased in 
the epidermis of Cbx4KO mice, whereas expression of Ring1b 
forming the canonical PRC1 complex together with Cbx4 and 
catalyzing the H2AK119 ubiquitylation was not changed (Fig. 
S2, A and B). Importantly, Cbx4 ablation changed neither 
H2AK119ub1 nor H3K27me3 expression in the dermal cells 
(Fig. S2 C), thus suggesting epidermis-specific effects of Cbx4 
on gene repression in the skin. These data were consistent with 
the data showing the significantly increased Cbx4 expression 
levels in the epidermis versus dermis in WT mice (Fig. 1 D) 
and suggested that, similar to other cell lineages, Cbx4 most 
likely mediates the recruitment of the canonical PRC1 complex 
to H3K27me3, followed by further ubiquitylation of H2AK119 
over its basal levels mediated by PRC1 in epidermal cells.
Our data also demonstrate that the expression levels of 
H2AK119ub1 in the epidermis of E18.5 Cbx4KO and WT mice 
became quite similar (Fig.  2, A and B), which suggests that 
other Cbx proteins (Fig. S1 C) might substitute for Cbx4 in the 
canonical PRC1 complex in Cbx4KO mice. These data are also 
quite consistent with the data demonstrating that maximal dif-
ferences in the epidermal thickness and proliferation between 
WT and Cbx4KO mice are seen at E16.5, whereas such differ-
ences become insignificant at E18.5 (Fig. 1, E–H).
To determine the molecular targets of Cbx4 in the epi-
dermal KCs during development, we correlated a microarray 
transcript profiling from E16.5 LCM-captured Cbx4-deficient 
basal cells with Cbx4 chromatin immunoprecipitation (ChIP) 
sequencing (ChIP-seq) analyses performed on primary epi-
dermal KCs isolated from E16.5 WT mice. About 13.8% of 
genes up-regulated in the basal epidermal cells from Cbx4KO 
mice showed Cbx4 ChIP-seq binding, thus likely representing 
direct Cbx4 targets in KCs (Fig.  2, E–G). Because the Cbx4 
chromodomain binds to H3K27me3, which results in a further 
increase of the H2AK119 ubiquitylation over its basal levels 
catalyzed by the PRC1 component Ring1b (Li et al., 2007; 
Luis et al., 2011), we merged data for direct Cbx4 targets and 
ChIP-seq data for H3K27me3 and found that 60.9% of Cbx4 
direct target genes in primary epidermal KCs show peaks for 
both Cbx4 and H3K27me3 within 100 kb of their transcription 
start sites (Fig. 2 E and Table S5). Furthermore, 12.1% of these 
genes showed the overlapping ChIP-seq peaks for Cbx4 and 
H3K27me3, thus pointing to these genes as direct targets for 
Cbx4-mediated repression (Table S5).
The DAV ID bioinformatics tool for gene ontology func-
tional annotation revealed an enrichment of the genes involved 
in the control of neuronal development among the Cbx4 targets 
(Fig. 2, F and G; and Table S5). In primary epidermal KCs, sev-
eral neuronal and other lineage-specific genes (Nefl, Neurog3, 
Mobp, En2, and Lhx4) contained both Cbx4 and H3K27me3 
ChIP-seq peaks in their regulatory regions (Fig. 2 H). Validation 
by qRT-PCR showed increased transcript levels of the selected 
Cbx4 target genes in the Cbx4-null epidermal cells (Fig. 2 I), 
including the Nefl and Mobp genes encoding a neurofilament 
light polypeptide and myelin-associated oligodendrocyte basic 
protein, structural components of the neurons, and Schwann 
cells, respectively (Montague et al., 1997; Jordanova et al., 
2003). In addition, expression of the Neurog3, Olig2, En2, and 
Lhx4 genes, encoding the corresponding transcription factors 
controlling the development of nervous system and some other 
non–KC cell lineages (Hobert and Westphal, 2000; Wallén and 
Perlmann, 2003; Pelling et al., 2011; Mitew et al., 2014), was 
markedly increased in the epidermis of Cbx4KO mice com-
pared with WT controls (Fig. 2 I).
Interestingly, Nefl transcript levels showed an inverse cor-
relation with Cbx4 expression in the WT epidermis during E11.5–
E16.5 (Figs. 1 A, 2 I, and S1 C). Further analysis revealed that, 
in addition to the dermal nerve fibers, an ectopic expression of 
the Nefl protein was seen in both basal and suprabasal epidermal 
layers of E16.5 Cbx4KO mice, whereas an exclusively neuronal 
Nefl expression was seen in WT mice (Fig. 2 J). Furthermore, 
ChIP–quantitative PCR (ChIP-qPCR) analyses showed enrich-
ments for Cbx4, H2AK119ub1, and H3K27me3 at the regulatory 
region of the Nefl gene, whereas a lack of Cbx4 enrichment was 
seen at the regulatory region of the Lor gene that did not belong 
to the category of the Cbx4 direct targets and served as a control 
in this experiment (Fig. 2 K). In addition, shRNA-mediated Cbx4 
gene silencing resulted in a significant decrease in the Cbx4 and 
H2AK119ub1 levels at the regulatory region of the Nefl gene in 
primary epidermal KCs, whereas the H3K27me3 levels were not 
changed (Figs. 2 L and S2 D). These data were consistent with 
the data demonstrating the decrease in the H2AK119ub1 levels in 
the epidermis of Cbx4KO versus WT mice (Fig. 2, A and B) and 
suggest that Cbx4 as a part of the canonical PRC1 complex facil-
itates repression of its target Nefl gene. However, Cbx4 ablation 
did not affect Merkel cell numbers in the developing epidermis or 
expression of the transcription factors (Atoh1 and Sox2) involved 
in their differentiation (Fig. 4, B and C; and Table S5; Van Key-
meulen et al., 2009; Bardot et al., 2013; unpublished data).
Chromodomain- and SUMO E3 ligase–
dependent Cbx4 activities differentially 
regulate proliferation, differentiation, and 
expression of nonepidermal genes in KCs
As Cbx4 uniquely possesses, among PRC1-associated Cbx 
subunits, both Polycomb and non-Polycomb SUMO E3 li-
gase activities (Li et al., 2007; Luis et al., 2011), we next 
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questioned whether its effects on epidermal proliferation, 
differentiation, and repression of nonepidermal genes seen 
during murine skin development are associated with one of 
these Cbx4 activities. We infected primary epidermal KCs 
isolated from newborn WT mice with retroviral constructs 
expressing either WT Cbx4 (Cbx4WT), chromodomain- 
mutated Cbx4 (Cbx4CDM), or E3 ligase–deficient Cbx4 
(Cbx4ΔSIM; Luis et al., 2011).
Interestingly, transfection of cells with Cbx4WT or Cbx4CDM 
constructs did not show any effect on the number of proliferating 
Ki67+ cells, whereas a prominent decrease in proliferation was seen 
in the cells expressing the E3 ligase–deficient Cbx4ΔSIM construct 
(Fig. 3, A and B). These data were consistent with the data show-
ing the decrease of epidermal proliferation in Cbx4KO mice (Fig. 1, 
G and H) and suggest that the effects of Cbx4 on proliferation in 
cultured KCs are mediated predominantly by its E3 ligase domain.
Figure 2. Activation of nonepidermal lineage genes in Cbx4-deficient epidermis. (A and B) Distribution and quantification of H2AK119ub1 immunofluo-
rescence in WT and Cbx4KO skin. H2AK119ub1 is markedly reduced in the Cbx4KO epidermis at E14.5 and E16.5, whereas its expression is restored 
by E18.5. (C and D) Lack of changes in the cutaneous H3K27me3 expression between WT and Cbx4KO mice. Dashed lines separate epidermis and 
dermis. (E) Overlap of the Cbx4 and H3K27me3 ChIP-seq data with the expression arrays obtained from the epidermis of Cbx4KO versus WT mice depicts 
the direct Polycomb-dependent Cbx4 target genes in KCs that are up-regulated upon Cbx4 ablation. (F) Ontology of the Cbx4 target genes using DAV ID 
bioinformatic resources. The bars represent the log10 p-values of each category. (G) Selected Cbx4 target genes involved in neuronal development and/
or functioning. (H) ChIP-seq tracks depicting Cbx4 and H3K27me3 binding to the selected target genes (a single representative experiment out of two 
repeats is shown). Dashed outlines depict the corresponding gene regulatory regions. (I) qRT-PCR validation of the selected Cbx4 target genes up-regulated 
in the basal progenitor cells from Cbx4KO mice versus WT controls (mean ± SD). n = 3. (J) Ectopic Nefl protein expression in the Cbx4KO epidermis (ar-
rowheads) compared with WT counterparts. Asterisks denote Nefl+ dermal nerve fibers in the WT and Cbx4KO mice. (K) ChIP-qPCR shows Cbx4 binding 
to Nefl but not to Lor promoter regions. Both Lor and Nefl are enriched in H2AK119ub1 and H3K27me3 histone marks (mean ± SD). n = 3. (L) Cbx4 
knockdown in primary mouse KCs with shRNA decreases Cbx4 binding and reduces the H2AK119ub1 enrichment on the Nefl promoter region (mean ± 
SD). n = 3. **, P < 0.01; ***, P < 0.001. Bars, 25 µm. ns, not significant.
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Given that Cbx4 suppresses senescence in human epi-
dermal KCs (Luis et al., 2011), we examined the mechanisms 
underlying the Cbx4-dependent regulation of the senescence- 
linked cell cycle inhibitor genes and performed ChIP-qPCR 
analyses that revealed Cbx4 binding to the Cdkn2a (p16/
p19) regulatory regions in primary epidermal KCs (Fig. S3 
C). Transfection of primary epidermal KCs with Cbx4WT or 
Cbx4CDM constructs showed that the Cbx4 chromodomain is 
involved in regulating the expression of Cdkn2a and Cdkn1c 
(p57; Fig. S3 D). Together with our data demonstrating an in-
crease in the expressions of p16/p19, p57, and the senescence 
marker γ-H2AX in the epidermis of Cbx4KO mice versus 
WT controls (Fig. S3, A, B, and E), these data demonstrated 
an involvement of the Cbx4 chromodomain in the control 
of expression of the senescence-associated p16/p19 and p57 
genes. These data were in full concordance with the data of 
Luis et al. (2011) that show similar effects of the Cbx4 chro-
modomain on the expression of senescence-associated genes 
in human epidermal KCs.
To assess whether targeting of Cbx4 in the primary 
KCs affects cell differentiation, we analyzed the expression 
of two established terminal differentiation–associated markers 
(Involucrin and Filaggrin) after infection of cells with the WT 
or mutated Cbx4-expressing retroviruses. Cbx4WT-expressing 
cells showed a decrease in protein and gene expression of In-
volucrin in comparison with control cells (Fig.  3, C and D). 
However, Cbx4ΔSIM-treated KCs showed a prominent in-
crease of Involucrin protein and gene expression compared 
with Cbx4WT- or Cbx4CDM-treated cells (Fig. 3, C, D, and 
G). Furthermore, transcripts of Flg were also increased upon 
Cbx4ΔSIM overexpression compared with the Cbx4WT and 
Cbx4CDM constructs (Fig.  3  H). Thus, similar to human 
epidermal progenitor cells (Luis et al., 2011), expression of 
terminal differentiation markers in mouse KCs occurs pre-
dominantly under the control of non-Polycomb SUMO E3 
ligase activity of Cbx4.
To further elucidate which of the Cbx4 activities were 
likely responsible for repression of the nonepidermal lineage 
genes, we analyzed Nefl expression in the response to over-
expression of the Cbx4 constructs harboring either chromo-
domain- or SUMO E3 ligase–mutated domains. A marked 
increase of both Nefl transcript and protein expression was 
detected in the Cbx4CDM-expressing cells compared with 
Cbx4WT and Cbx4ΔSIM (Fig. 3, E, F, and I). Thus, Cbx4 re-
presses neuronal gene Nefl in epidermal KCs predominantly via 
the Polycomb-mediated inhibitory pathway.
Figure 3. SUMO E3 ligase– and chromodomain-dependent activities of Cbx4 in the epidermal progenitor cells. (A–F) Immunofluorescent detection and 
quantification of Ki67 (A and B), Ivl (C and D), and Nefl (E and F) expression in the primary mouse KCs infected with Cbx4WT-, Cbx4CDM-, and Cbx-
4ΔSIM-expressing retroviruses. The number of Ki67+-proliferating cells is significantly reduced, whereas Ivl expression is markedly increased in Cbx4Δ-
SIM-expressing KCs. In contrast, Nefl expression is up-regulated in Cbx4CDM-expressing cells (mean ± SD). n = 3. Bars, 50 µm. (G and H) qRT-PCR shows 
increased Ivl (G) and Flg (H) transcription in Cbx4ΔSIM-expressing cells (mean ± SEM). n = 3. (I) Increased levels of the Nefl transcripts in primary mouse 
KCs infected with Cbx4CDM-expressing retrovirus (mean ± SEM). n = 3. *, P < 0.05; **, P < 0.01; ***, P < 0.001. ns, not significant.
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Cbx4 is a direct p63 target mediating 
its inhibitory activity on nonepidermal 
genes in KCs
p63 is a major transcriptional regulator of epidermal develop-
ment with multiple functions, including a direct positive tran-
scriptional regulation of epidermal genes such as keratins and 
adhesion molecules (Koster and Roop, 2007; Vanbokhoven et 
al., 2011; Botchkarev and Flores, 2014; Kouwenhoven et al., 
2015). A recent study has also highlighted an important role for 
p63 in suppression of nonepidermal lineage genes (De Rosa et 
al., 2009). To test whether p63-dependent suppression of the 
nonepidermal genes is mediated by Cbx4, we compared the 
transcriptomes of epidermal cells isolated by LCM from E18.5 
Cbx4KO and p63KO embryos. A significant portion (34.7%) of 
the genes (716 out of 2,059) up-regulated in the p63-deficient 
KCs were also up-regulated in Cbx4KO basal epidermal cells, 
suggesting a functional link between p63 and Cbx4 (Fig. 4 A 
and Table S2). Furthermore, ChIP-seq analyses showed that 
72 of these genes, including the Nefl gene, served as direct 
Cbx4 targets in KCs (Fig. 4 A and Table S2). The expression 
changes of the Nefl gene were further validated by qRT-PCR 
in p63-deficient KCs isolated from p63KO embryos and p63 
siRNA–treated primary mouse KCs (Fig. 4, B and C). Similar 
to Cbx4KO epidermal cells, p63-deficient skin epithelial cells 
showed strongly up-regulated Nefl protein expression com-
pared with WT cells (Fig. 4, D and E), further substantiating 
functional cooperation between p63 and Cbx4 in the repression 
of nonepidermal genes in the developing epidermal KCs.
To further investigate the relationships between p63 and 
Cbx4, we analyzed Cbx4 expression in p63KO embryonic skin. 
Both the Cbx4 transcript and protein levels were markedly re-
duced in the p63-deficient KCs (Fig.  4, F–H). Interestingly, 
in p63KO dermal cells, Cbx4 protein expression was detect-
able at similar levels to control mice (Fig. 4 G), suggesting a 
KC-specific Cbx4 regulation by p63 transcription factor. By 
using a PatSearch tool (Grillo et al., 2003), we identified a 
highly conserved region ∼5.5 kb upstream of the Cbx4 tran-
scription start site containing several putative p63-binding sites 
(Fig. 4 I). Furthermore, ChIP revealed binding of the p63 tran-
scription factor to the identified region in primary mouse KCs 
in vivo (Fig. 4 J). We cloned a 2.4-kb Cbx4 5′ UTR fragment, 
containing the putative p63-binding sites as an enhancer, into 
the pGl3 promoter plasmid (pGl3-Cbx4-luc) and coexpressed 
it with either ΔNp63-expressing or empty vector in the im-
mortal KC HaCaT cell line. A marked increase in luciferase 
activity was seen in cells coexpressing pGl3-Cbx4-luc with 
pΔNp63 vectors compared with a control plasmid (pFLAG-
CMV2; Fig. 4 K), thus showing a direct transcriptional regula-
tion of Cbx4 by p63 in KCs.
Ectopic Cbx4 expression partially rescues 
the epidermal phenotype in embryonic skin 
explants of p63-deficient mice
To assess whether the restoration of Cbx4 expression is capable 
of partially rescuing the skin phenotype of p63KO mice, E13.5 
skin explants isolated from p63 heterozygous (p63+/−) mice 
were cultured ex vivo and infected with p63 shRNA–expressing 
lentiviruses in combination with either Cbx4-expressing or con-
trol lentiviruses (Fig. 5, A–E). Compared with the p63+/− skin 
explants treated with control viruses, treatment with p63 shRNA 
in combination with control lentiviruses resulted in a marked 
decrease of the epidermal thickness, cell proliferation, and ex-
pressions of epidermal keratins K14 and K10, thus reproducing 
in part the skin phenotype of p63KO mice (Fig. 5, A–E). How-
ever, cotreatment of p63+/− skin samples with p63 shRNA– and 
Cbx4-expressing lentiviruses resulted in a significant increase of 
epidermal thickness, cell proliferation, and K14/K10 expression 
compared with the samples treated with p63 shRNA and control 
lentiviruses (Fig.  5, A–E). The restoration of epidermal prolif-
eration after ectopic Cbx4 expression was consistent with data 
showing reduced cell proliferation in the epidermis of Cbx4KO 
mice compared with WT controls (Fig. 1, G and H). Furthermore, 
the Nefl protein was strongly decreased in the epithelium of p63- 
deficient embryonic skin explants transduced with Cbx4 (Fig. 5, 
D and E), suggesting that Cbx4 is indeed capable of inhibiting its 
expression in epidermal KCs ex vivo. Therefore, Cbx4 plays a 
role in mediating the p63-dependent program of gene repression 
during epidermal development and is capable of partially restor-
ing the epidermal phenotype of p63-deficient mice.
Discussion
Polycomb-dependent transcriptional repression is a powerful 
mechanism that shapes gene expression programmers in es-
sentially all cell types of living organisms during development 
and postnatal homeostasis, whereas alterations in the patterns 
of Polycomb-dependent gene repression contribute to many 
pathological conditions including carcinogenesis (Simon and 
Kingston, 2013). Polycomb PRC1 and PRC2 are multiprotein 
complexes, and despite the fact that the role of some Polycomb 
genes, such as Ezh1/2, in execution of terminal differentiation 
programmers in the epidermis and hair follicles was shown pre-
viously (Ezhkova et al., 2009, 2011), the effects of the other 
PRC1/2 components on the establishment of lineage-specific 
patterns of gene repression during skin development and epi-
dermal differentiation remain unclear. Here, we show that 
PRC1 component Cbx4 plays a unique role in the establishment 
and maintenance of the KC lineage identity and represses none-
pidermal lineage (neuronal) genes in the epidermal progenitor 
cells, as well as controls proliferation and inhibits premature 
differentiation in basal epidermal KCs.
We demonstrate that among different PRC1 genes, Cbx4 
shows the most prominent changes in its expression in the em-
bryonic epidermis during its stratification, where Cbx4 is seen 
in basal and suprabasal KCs. Genetic Cbx4 ablation results in 
a marked decrease of epidermal thickness and proliferation, as 
well as in the premature appearance of the terminal differen-
tiation markers in the immediate suprabasal epidermal cells. 
Interestingly, Ezh2KO mice also show a decrease of epidermal 
proliferation and premature terminal differentiation (Ezhkova 
et al., 2009). Similar to Ezh2KO mice (Ezhkova et al., 2009), 
Cbx4-null mice show an increase of the p16/p19 and p57 cell 
cycle inhibitor genes in the epidermis, which, at least in part, 
explains the stimulatory effects of Cbx4 on epidermal prolifer-
ation. However, in contrast to Ezh2KO mice, Cbx4 genetic ab-
lation results in a marked decrease of the epidermal thickness, 
suggesting that Cbx4 plays a unique yet partially overlapping 
role with Ezh2 in the control of epidermal development.
The decreased cell proliferation observed in the epider-
mis upon Cbx4 ablation is consistent with our previous results 
that show reduced cell proliferation and thymus hypoplasia in 
Cbx4KO mice (Liu et al., 2013). In contrast to other Cbx proteins, 
Cbx4 uniquely possesses both Polycomb and non-Polycomb 
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SUMO E3 ligase activities (Li et al., 2007; Luis et al., 2011). 
We show here that in cultured primary epidermal KCs, only the 
non-Polycomb E3 ligase–deficient Cbx4 (Cbx4ΔSIM) is capa-
ble of inhibiting proliferation, suggesting that the SUMO E3 li-
gase activity of Cbx4 contributes to the alterations of epidermal 
proliferation in Cbx4KO mice.
Interestingly, KCs treated with Cbx4ΔSIM also show a 
marked increase in the expression of terminal differentiation– 
associated markers, such as Involucrin or Filaggrin, thus suggest-
ing that non-Polycomb SUMO E3 ligase Cbx4 activity might also 
inhibit the premature activation of terminal differentiation genes 
in the epidermis. These data are consistent with data demonstrat-
ing an involvement of SUMO E3 ligase Cbx4 activity in inhib-
iting differentiation in human epidermal progenitor cells (Luis 
et al., 2011). However, additional analyses are required to fully 
understand the mechanisms underlying the effects of the SUMO 
E3 ligase domain of Cbx4 in regulating gene expression in KCs.
Our data also reveal that the Cbx4 chromodomain is in-
volved in the repression of the senescence-associated Cdkn2a 
gene, whereas Cbx4 ablation results in the accumulation of 
H2AX as one of the senescence markers (Turinetto and Gia-
chino, 2015) in epidermal KCs. These data are in full con-
cordance with the data of Luis et al. (2011) that show similar 
effects of the Cbx4 chromodomain on the expression of senes-
cence-associated genes in human epidermal KCs.
Histone methyltransferase Ezh2 catalyzing H3K27 
trimethylation plays an important role in the prevention of 
premature activation of terminal differentiation genes in basal 
epidermal KCs (Ezhkova et al., 2009). The Cbx4 chromo-
domain mediates the targeting of the canonical PRC1 complex 
to H3K27me3, leading to the increase of H2AK119 ubiquityl-
ation over its basal levels catalyzed by the PRC1 component 
Ring1b (Simon and Kingston, 2013; Cheutin and Cavalli, 2014; 
Perdigoto et al., 2014; Schwartz and Pirrotta, 2014). Although 
Figure 4. Cbx4 serves as a direct p63 target in epidermal KCs. (A) Overlap of the Cbx4 target genes commonly up-regulated in laser-captured epidermis 
of E16.5 Cbx4KO and p63KO mice. (B and C) qRT-PCR validation of Nefl gene up-regulation in the epidermal progenitor cells in p63KO mice (B) and 
primary epidermal KCs expressing p63 shRNA (C; mean ± SD). n = 3. (D) Increased Nefl protein expression in the epidermis of p63 mutant mice (arrow-
heads). Nefl-expressing dermal nerve fibers are shown by arrows. Dashed lines separate epidermis and dermis. (E) The number of Nefl+ epidermal cells 
is significantly increased in p63KO mice (mean ± SD). n = 3. (F and G) Cbx4 transcript (F) and protein (G) are markedly down-regulated in the epidermis 
of p63KO mice (mean ± SD). n = 3. Dashed lines separate epidermis and dermis. (H) A significant reduction in the number of Cbx4+ cells in p63KO skin 
compared with WT skin (mean ± SD). n = 3. (I) Conserved putative p63-binding sites are identified by the PatSearch tool in the mouse and human Cbx4 5′ 
UTR. Asterisks indicate consensus sequences for p63-binding sites, and core sequence elements are indicated by red asterisks. (J) ChIP-qPCR showing p63 
binding to the identified region in the mouse Cbx4 5′ UTR. (K) A 2.4-kb region in the Cbx4 5′ UTR increases minimal SV40-promoter activity (pGl3-Cbx4-
luc) upon coexpression with a ΔNp63-expressing construct compared with an empty plasmid (pFLAG-CMV2). Bars, 25 µm. **, P < 0.01; ***, P < 0.001.
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the levels of H3K27me3 were not altered in the epidermis of 
Cbx4KO mice, Cbx4 ablation resulted in a marked decrease 
in H2AK119Ub in the epidermis (presumably to its basal lev-
els) compared with WT controls. The fact that Cbx4-null mice 
showed reduced levels of H2AK119Ub only in the epidermis, 
whereas H2AK119Ub levels in the dermal cell were not altered 
upon Cbx4 ablation compared with WT controls, points to the 
specificity of this interaction.
Interestingly, Cbx4 ablation is also accompanied by an in-
crease of epidermal expression of Kdm2b histone demethylase 
that forms a noncanonical PRC1 complex together with PCGF1 
and RYBP and promotes basal ubiquitylation of H2AK119 at 
unmethylated CpG-rich DNA regions (Blackledge et al., 2014; 
Cooper et al., 2014; Kalb et al., 2014). These data suggest that 
interaction of the noncanonical PRC1 complex with gene tar-
gets is likely not altered in the epidermis of Cbx4KO mice and 
that the Cbx4 chromodomain is specifically involved in the 
execution of the canonical PRC1-mediated gene repression 
in the epidermis via interaction with H3K27me3 followed by 
H2AK119 ubiquitylation.
However, a correlation between the Cbx4 and Ezh1/2 
ChIP-seq targets in epidermal KCs might help in addressing the 
roles for PRC1 and PRC2 complexes in repressing the activities 
of the distinct gene groups in KCs. Our data reveal a contribution 
of the Cbx4 chromodomain to the repression of non-KC lineage 
(neuronal) genes in the epidermis, which is quite consistent with 
the data obtained from the Ezh2KO mice (Ezhkova et al., 2009). 
By merging the microarray data obtained from the epidermis of 
Cbx4KO mice with Cbx4 ChIP-seq and H3K27me3 ChIP-seq 
data, we demonstrate an enrichment of the genes associated with 
nervous system development among the direct Cbx4 targets in 
KCs. We show that several key genes encoding structural com-
ponents of the neurons and Schwann cells (Nefl and Mobp) and 
transcription factors involved in the control of nervous system 
development (Neurog3, Olig2, En2, and Lhx4) are up-regulated 
in the epidermis of Cbx4KO mice compared with WT controls.
Epidermal and neuronal lineages share the common ecto-
dermal origin (Patthey and Gunhaga, 2011; Benitah and Frye, 
2012), and mechanisms that control gene repression during 
specification of these two lineages in the embryo are unclear. 
Ezh2 is strongly expressed in neural stem cells and is down- 
regulated during their differentiation into neurons and astrocytes, 
whereas its expression is increased during neural stem cell dif-
ferentiation into the oligodendrocyte lineage (Sher et al., 2008). 
Analyses of the Ezh2 targets in neural stem cells (Sher et al., 
2012) reveal that several genes encoding transcription factors in-
volved in the control of nervous system development (En2, Lhx4, 
Olig2, Pax3, and Pitx2) also represent the direct Cbx4 targets in 
epidermal KCs. These data support an idea that Cbx4, through its 
chromodomain, and Ezh2 operate in concert to repress neuronal 
genes and maintain the epithelial fate in the epidermal progenitor 
cells, whereas Ezh2 also represses their differentiation into the 
Merkel cell lineage independently of Cbx4 (Bardot et al., 2013).
Specification and differentiation of the epidermal progeni-
tor cells during development is supported by the p63 transcription 
Figure 5. Cbx4 partially rescues an epidermal phenotype in p63KO mice. 
(A and B) Hematoxylin/AP staining (A) and immunodetection of Ki67+-pro-
liferating cells (B) in E13.5 ex vivo embryonic skin explants of heterozy-
gous p63+/−KO mice treated with p63 shRNA– and Cbx4-expressing 
lentiviruses. Dashed lines separate epidermis and dermis. (C) Cbx4 over-
expression in p63-deficient epidermal cells significantly increases epi-
dermal thickness and cell proliferation (mean ± SD). n = 3.  (D and E) 
Quantitative immunofluorescence stainings with anti-K14, anti-K10, and 
anti-Nefl antibodies show down-regulation of K14/K10 and up-regulation 
of Nefl (arrows) in the epithelium of p63-deficient skin explants. Cotreat-
ment of the explants with p63 shRNA– and Cbx4-expressing lentiviruses 
results in up-regulation of K14/K10 expression and down-regulation of 
Nefl expression in p63-deficient epidermis. Integrin-β4 (Itgb4) expression 
outlines the basement membrane of the epidermis. DAPI counterstain (blue) 
shows the nuclei (mean ± SD). n = 3. **, P < 0.01; ***, P < 0.001. (F) 
Scheme summarizing the p63-/Cbx4-mediated effects on gene repression 
in the developing epidermis. Bars, 25 µm.
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factor that serves as a master regulator of epidermal development 
(Koster and Roop, 2007; Vanbokhoven et al., 2011; Botchkarev 
and Flores, 2014; Kouwenhoven et al., 2015). Increased evidence 
demonstrates that p63 regulates several components of the epi-
genetic machinery (Brg1, Lsh, and Satb1) to regulate chromatin 
remodeling and establish the epidermal differentiation program 
(Fessing et al., 2011; Keyes et al., 2011; Mardaryev et al., 2014).
We show here that p63 also operates as a direct upstream 
regulator of Cbx4, which mediates its effects on cell prolifera-
tion and is involved in the repression of non-KC lineage genes. 
We showed previously that p63 directly interacts with Cbx4 in 
thymocytes, suggesting a possibility for both proteins to form 
a transcription complex to regulate expression of target genes 
(Liu et al., 2013). Consistently, comparison of the microarray 
data from the skin epithelium of p63KO mice and epidermis 
of Cbx4KO mice reveals that ∼35% of the genes up-regulated 
in the skin epithelium of p63KO mice are also up-regulated in 
the epidermis of Cbx4 mutants, whereas ∼10% of these genes 
represent direct Cbx4 targets in KCs. Furthermore, we show 
that Cbx4 expression is markedly decreased in the skin epithe-
lium of p63KO mice, p63 shows binding to the Cbx4 regulatory 
region and stimulates Cbx4 promoter activity, and Cbx4 is ca-
pable of partially rescuing alterations of KC proliferation upon 
p63 ablation in skin organ cultures.
Collectively, these data provide compelling evidence that 
Cbx4 operates as an important part of the p63-regulated program 
of establishing and maintaining epithelial cell fate in epider-
mal progenitors and that Cbx4-mediated repression of non-KC 
lineage genes serves as a crucial component of this program 
(Fig. 5 F). However, additional analyses are required to fully un-
derstand the complexity of Cbx4-dependent gene repression in 
epidermal KCs. In particular, the role of Cbx4 in the repression 
of other lineage-specific genes, including mesodermal genes in 
KCs, and the potential contribution of these genes in the con-
trol of epithelial–mesenchymal transition need to be carefully 
explored. Also, the roles of other members of the Cbx family, 
including Cbx6 and Cbx7, which might substitute for Cbx4 in 
the canonical PRC1 complex and partially compensate for the 
effects of Cbx4 ablation in epidermal KCs, need to be clarified.
Because skin contains a large variety of the progenitor 
cells for distinct cell lineages (epithelial, neuronal, and mes-
enchymal; Hunt et al., 2009), future research in this direction 
will shed light on the role of distinct Cbx family members in 
the control of progenitor cell differentiation and/or reprogram-
ming isolated from the skin. This will also help to design novel 
approaches for modulating gene expression programmers in 
healthy and diseased skin via targeting the activity of Cbx genes.
Materials and methods
Animals and tissue collection
All animal studies were performed under protocols approved by a Home 
Office Project License. C57BL/6 mice were purchased from Charles 
River. Skin samples were collected from mice at distinct days of em-
bryonic and postnatal development (E11.5, E14.5, E16.5, E18.5, P1.5, 
and P56). p63KO embryos were obtained by breeding p63+/− animals 
purchased from The Jackson Laboratory. Generation of Cbx4KO mice 
was described previously (Liu et al., 2013). In brief, the N-terminal 
region of the Cbx4 gene including the first two exons and a 0.9-kb up-
stream region was targeted for Cbx4 gene disruption. The null allele was 
gained upon Cre-loxP excision by crossing mice carrying the floxed allele 
with EIIa-Cre transgenic mice to achieve global gene KO, and the mice 
were bred on the C57BL/6J-129Sv genetic background. Genotyping of 
mice was performed using PCR, as described previously (Liu et al., 2013). 
For each developmental stage, six to seven samples were collected. Tissue 
samples were snap frozen in liquid nitrogen, embedded into optimal cut-
ting temperature medium (VWR), and processed for immunofluorescent 
or LCM and microarray analyses as described in the following paragraph.
LCM, microarray, and qRT-PCR analysis
LCM of mouse basal KCs at selected stages of development was per-
formed followed by RNA isolation, amplification, and microarray analysis 
as previously described (Sharov et al., 2006, 2009). In brief, 8-µm-thick 
frozen skin cryosections were dehydrated to preserve RNA integrity, and 
LCM was performed from the epidermis of WT, Cbx4KO, and p63KO 
mice at E11.5, E16.5, P0.5, and P56 using an LCM system (Arcturus; Life 
Technologies). Total RNAs were isolated using an RNA isolation kit (Pi-
coPure; Life Technologies) followed by two rounds of linear RNA ampli-
fication using an RNA amplification kit (RiboAmp; Life Technologies). 
Equal amounts of RNA from each sample were labeled by Cy3 using a 
fluorescent labeling kit (Agilent Technologies). Quality and size distribu-
tion of the targets was determined by an RNA 6000 Nano Lab-on-a-chip 
assay (Agilent Technologies), and quantification was determined using 
a microscale spectrophotometer (NanoDrop). After one round of linear 
amplification in all analyses, Universal Mouse Reference RNA (Agilent 
Technologies) was used as a control. All microarray analyses were per-
formed by MOgene, LC, using the 41K Whole Mouse Genome 60-mer 
Oligo Microarray kit (Agilent Technologies). All microarray data were 
normalized to the corresponding data obtained from the reference RNA. 
Two independent datasets were obtained from WT and transgenic mice, 
and p-values were calculated by Feature Extraction software (version 7.5; 
Agilent Technologies) using distribution of the background intensity val-
ues to signal intensity and using a Student’s t test.
For qRT-PCR analysis of RNA isolated and amplified after 
LCM, PCR primers were designed on Beacon Designer software (PRE 
MIER Biosoft International; Table S3). RT-PCR was performed using 
iQ SYBR green Supermix and the MyiQ Single-Color Real-Time PCR 
Detection System (Bio-Rad Laboratories). Differences between sam-
ples and controls were calculated using the Gene Expression Macro 
program (Bio-Rad Laboratories) based on the ΔΔCt equitation method 
with glyceraldehyde 3-phosphate dehydrogenase and peptidylprolyl 
isomerase A genes as internal housekeeping controls.
Plasmids
Cbx4WT and Cbx4-mutated retroviral plasmids (Cbx4CDM and 
Cbx4ΔSIM) were previously validated (Luis et al., 2011). In brief, 
Cbx4 cDNA was cloned into pMSCV and pMSCV-Puro-IRES-
GFP. The chromodomain was mutated using the QuikChange II 
XL Site-Directed Mutagenesis kit (Agilent Technologies) to cre-
ate the F11A and W35L double mutants. In Cbx4ΔSIM plasmid (a 
gift from D.  Wotton, University of Virginia, Charlottesville, VA), 
Cbx4 cDNA was mutated to harbor internal deletion of nucleotides 
at the 784–795 and 1,381–1,404 positions, corresponding to both 
SIM1 (IVIV) and SIM2 (EVI LLDSD) amino acid sequences, re-
spectively (Merrill et al., 2010). Cbx4 knockdown was done using 
a validated shRNA construct (5′-CCG GCGAC ACCAG TAACC 
TTGGT ATCTC GAGAT ACCAA GGTTA CTGGT GTCGT TTTTG-3′)  
cloned into pLKO.1-GFP lentiviral plasmid (Morey et al., 2012). 
pGIPZ–p63 shRNA lentiviral plasmid (V3LMM_508694; GE Health-
care) contains a 5′-TGA TCTTC AGCAA CATCTC-3′ sequence and was 
used to target p63. pHAGE2-EF1-mCbx4 lentiviral plasmid was pro-
duced by cloning PCR-amplified mouse Cbx4 cDNA into pHAGE2-EF1 
vector (a gift from G. Mostoslavsky, Boston University, Boston, MA).
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Production of the Cbx4 and p63 expression and knockdown viruses
Cbx4WT-, Cbx4CDM-, and Cbx4ΔSIM-expressing retroviruses were 
produced by transfection of Phoenix-E/HEK293T packaging cells. 
Cbx4 shRNA– and p63 shRNA–expressing lentiviruses were pro-
duced by cotransfection of HEK293T cells with pLKO.1-EGFP-Cbx4 
shRNA or pGIPZ–p63 shRNA and packaging (psPAX2) and envelope 
(pMD2.G) plasmids. For Cbx4-expressing lentiviruses, HEK293T 
cells were cotransfected with pHAGE2-EF1-mCbx4 and helper plas-
mids (pTAT, pREV, pHagp2(GAG/Pol), and pVSV-G) as published 
elsewhere (Mostoslavsky et al., 2005). For Cbx4-mutated retroviruses, 
Phoenix-E cells were transfected with pMSCV-PIG-CBX4-WT, pM-
SCV-PIG-CBX4-CDM, and pMSCV-PIG-CBX4-ΔSIM plasmids as 
published previously (Luis et al., 2011). Cell culture medium con-
taining viruses was collected 24 h, 48 h, and 78 h after transfection, 
followed by precipitation of the viral particles using PEG-it solution 
(System Biosciences) as per the manufacturer’s protocol.
Primary mouse KC culture
Epidermis from newborn C57BL/6 was separated from dermis by over-
night digestion with 0.25% trypsin at 4°C. Epidermal sheath was added 
to prechilled, supplemented, low-calcium KC culture medium (MEM, 
4% FBS, 0.05-mM CaCl2, 0.4 µg/ml hydrocortisone, 5 µg/ml insulin, 10 
mg/ml EGF, 10−10-M cholera toxin, 2 × 10−9 T3, 2-mM l-glutamine, 100 
U/ml penicillin, and 100 µg/ml streptomycin). To make a single-cell sus-
pension, the epidermal tissue was chopped with scissors and triturated, 
followed by filtering through a 70-µM silicon strainer and plating onto 
collagen-coated plates and coverslips. Primary cells were grown in the 
KC culture medium at 33°C and 5% CO2 until 60–70% confluent and in-
fected with the retroviral/lentiviral particles. Cells were collected for sub-
sequent qRT-PCR or immunofluorescent analyses 48 h after infection.
FACS
A single-cell suspension of newborn epidermal KCs was prepared as de-
scribed in the previous paragraph. To ensure analysis and sorting of viable 
cells with intact chromatin, KCs were stained with UV Live/Dead Fix-
able Dye (Life Technologies) for 30 min on ice before fixation with 1% 
PFA for 10 min at RT. Fixed cells were labeled with CD49f-phycoeryth-
rin and Sca-1–FITC antibodies (Table S4) for 1 h on ice. CD49f+/Sca-1+ 
basal KCs were gated after exclusion of dead cells and sorted on a cell 
sorter (MoFlo XDP; Beckman Coulter) as described elsewhere (Jensen 
et al., 2010). Sorted cells were pelleted at 2,000 g and stored at −80°C.
Luciferase reporter assay
To make the pGl3-Cbx4-luc plasmid, a 2.4-kb Cbx4 enhancer region 
(−5,954/−3,523 bp upstream of the Cbx4 transcription start site) was 
PCR amplified from genomic DNA and cloned into the Luciferase re-
porter plasmid pGl3 promoter (Promega) at BamHI–SalI sites using 
the In-Fusion HD Cloning System (Takara Bio Inc.). For the reporter 
assay, HaCaT cells were seeded into white-bottomed/white-walled 
96-well plates at 10,000 cells/well, and transfections were performed 
after overnight incubation at 37°C. Cells were transfected with 200 ng 
DNA total plus 10 ng pRLTK Renilla Control vector (Promega): 100 ng 
pGl3-Cbx4-luc and 100 ng pΔNp63 or empty pFLAG-CMV2 vectors. 
After 48  h of incubation at 37°C, cells were washed with PBS, and 
the assay was performed using the Dual-Glo Luciferase Assay System 
(Promega) according to the manufacturer’s protocol. Firefly luciferase 
activity was normalized against the Renilla luciferase activity, and the 
data represent three independent triplicates.
Histology and immunohistochemistry
For histology and histomorphometry, 8-µm cryosections were fixed in 
4% PFA for 10 min at RT followed by hematoxylin staining and AP 
activity visualization using histoenzymatic reaction (Botchkareva et 
al., 1999, 2000; Ahmed et al., 2011, 2014). Epidermal thickness was 
measured in 10 microscopic fields using ImageJ software (National In-
stitutes of Health). For immunohistochemistry, 8-µm cryosections were 
fixed in 4% PFA for 10 min at RT and incubated with primary antibod-
ies (Table S4) overnight at 4°C, followed by application of correspond-
ing Alexa Fluor 488 and Cy-555–coupled secondary antibodies (1:200; 
Life Technologies) for 60 min at 37°C. Cell nuclei were visualized with 
4′6′-diamidino-2-phenylindol. Images were acquired on a microscope 
(Eclipse 50i; Nikon) with 20×/0.50 NA and 40×/0.75 NA Plan Fluor 
objectives (Nikon) using a digital camera (ExiAqua; QImaging) and 
Image-Pro Express 6.3 image analysis software (QImaging).
Comparative analysis of Ki67+, Ivl+, Nefl+, and Cbx4+ cells was 
done by evaluating the ratio of the number of positive cells to DAPI+ 
cells, as descried previously (Sharov et al., 2003, 2005; Mardaryev et 
al., 2011). For quantification of Ki67+ and Cbx4+ cells in tissue cryo-
sections, 10 microscopic fields (20×) from three WT and Cbx4KO skin 
sections were included in the analysis. For quantification of Ki67+, Ivl+, 
and Nefl+ cells cultured in vitro, five microscopic fields (20×) taken 
from the center and each of the four sides of the well were used in 
the analysis. Data were pooled, the means ± SD were calculated, and 
statistical analysis was performed using a two-tailed t test (α = 0.05).
Immunofluorescence intensity was determined using ImageJ soft-
ware as described previously (McCloy et al., 2014). In brief, red or green 
fluorescent signals were collected from experimental tissues in RGB for-
mat using the same exposure conditions. To measure the fluorescence 
intensity at each pixel, the RGB images were converted to 8-bit gray-
scale format. Regions of interest of distinct size were selected within WT 
or Cbx4KO epidermis and dermis, and the corrected values of total cell 
fluorescence were calculated for each selected area using the following 
formula: corrected total cell fluorescence = integrated density − (area of 
selected cell × mean fluorescence of background readings). For pairwise 
comparisons, a two-tailed t test (α = 0.05) was used. Where multiple sam-
ples were compared, a one-way analysis of variance (ANO VA) was used, 
followed by the Newman–Keuls test (α = 0.05).
ChIP-seq and ChIP-qPCR assays
ChIP was performed using epidermal KCs isolated from newborn 
mouse skin and anti-H3K27me3, anti-Cbx4, and anti-H2AK119ub1 
antibodies (Table S5). In brief, a single-cell suspension of mouse epi-
dermal KCs was prepared after overnight digestion in 5 mg/ml dispase 
(Roche) at 4°C, followed by a 5-min treatment with 0.2% trypsin (Life 
Technologies). Basal epidermal KCs were sorted by FACS and further 
processed using a ChIP-IT High Sensitivity kit (Active Motive). 5 × 
106 PFA-fixed cells were used as a starting material. Indexed ChIP-
seq libraries were generated using NEBNext reagents (New England 
Biolabs, Inc.), and ChIP libraries were sequenced on the HiSeq 2500 
platform (Illumina), producing 30–70 million reads per library. Se-
quencing reads were aligned to the mm9 mouse genome assembly 
(University of California, Santa Cruz, Genome Browser). Specific 
areas of binding were identified with Sicer using default settings. For 
ChIP-qPCR, precipitated DNA was analyzed using primers designed 
for the promoter regions of Cbx4, Lor, Nefl, and Cdkn2a genes (Table 
S3). ChIP-qPCR data were pooled, means ± SD were calculated, and 
statistical analysis was performed using a one-way ANO VA test as 
described previously (Mardaryev et al., 2011).
Embryonic tissue culture
Whole dorsal skin culture from E13.5 p63+/− embryos were prepared 
and maintained as previously described (Botchkarev et al., 1999). In 
brief, skin samples were dissected from embryos and cultured in the 
6-well plates containing Williams’ medium E. Within 2 h after the cul-
 o
n






Published December 28, 2015
JCB • Volume 212 • NumBer 1 • 201688
ture preparation, tissue samples were infected with p63 shRNA lentivi-
rus in combination with either Cbx4-expressing or control lentiviruses 
and the addition of 10 µg/ml polybrene (Sigma-Aldrich) for 48 h. The 
tissue was frozen and embedded into optimal cutting temperature me-
dium for subsequent immunofluorescent and qRT-PCR analyses.
Online supplemental material
Fig. S1 shows expression of the PRC1/PRC2 and Nefl genes in mouse 
epidermis during development. Fig. S2 shows characterization of the 
changes in gene expression in the epidermis of Cbx4KO mice and in 
primary KCs after Cbx4 knockdown. Fig. S3 shows analyses of the 
senescence and apoptotic markers in WT and Cbx4-deficient skin. Fig. 
S4 shows the details of the epidermal and Merkel cell differentiation 
in Cbx4KO and WT mice. Table S1 shows expression of the PRC1 
and PRC2 genes in epidermal KCs at different stages of epidermal 
development. Table S2 shows Cbx4 target genes up-regulated in the 
skin epithelium of p63KO mice. Tables S3 and S4 present a list of 
primers used for qRT-PCR analyses and a list of antibodies used in 
this study, respectively. Table S5 shows Cbx4 target genes in epidermal 
KCs. Online supplemental material is available at http ://www .jcb .org /
cgi /content /full /jcb .201506065 /DC1.
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Table S5. Cbx4-dependent Polycomb targets in mouse epidermal progenitor cells 
















ATP-binding cassette, sub-family A (ABC1), member 
8b (Abca8b) [NM_013851] 
6.7 109891303 109892702 109892065 109893060 
Abcb4 
ATP-binding cassette, sub-family B (MDR/TAP), 
member 4 (Abcb4) [NM_008830] 
166.7 8861441 8862016 8893021 8894618 
Ablim1 actin-binding LIM protein 1 3.8 57377643 57378322 57396863 57400086 
Acaa2 
acetyl-Coenzyme A acyltransferase 2 (mitochondrial 
3-oxoacyl-Coenzyme A thiolase) (Acaa2), nuclear 
gene encoding mitochondrial protein [NM_177470] 
4.1 74965315 74965865 74958473 74960177 
Acacb 
acetyl-Coenzyme A carboxylase beta (Acacb) 
[NM_133904] 
2.2 114614986 114615883 114595162 114596740 
Accn1 
amiloride-sensitive cation channel 1, neuronal 
(degenerin) (Accn1), transcript variant MDEG2 
[NM_007384] 
4.9 81757576 81758271 81779017 81782808 
Acot12 acyl-CoA thioesterase 12 (Acot12) [NM_028790] 6.7 91877528 91878424 91880131 91881976 
Actr3b ARP3 actin-related protein 3B 12.7 25274562 25275337 25319588 25321790 
Adam1b 
a disintegrin and metallopeptidase domain 1b 
(Adam1b) [NM_172125] 
2.2 121943925 121945418 121952680 121954960 
Adam23 
a disintegrin and metallopeptidase domain 23 
(Adam23),   [NM_011780] 
26.8 63504710 63505387 63491467 63493602 
Adar 
adenosine deaminase, RNA-specific (Adar),   
[NM_001038587] 
2.1 89428375 89429316 89538275 89541141 
Adck1 aarF domain containing kinase 1 4 89609890 89611017 89619351 89620799 
Adck3 
aarF domain containing kinase 3 (Adck3), nuclear 
gene encoding mitochondrial protein,   [NM_023341] 
59.7 182144228 182145215 182144274 182147470 
Adcy1 adenylate cyclase 1 (Adcy1) [NM_009622] 6.1 7001305 7002626 6962317 6969103 
Adcy5 adenylate cyclase 5 (Adcy5) [NM_001012765] 8.3 35093984 35094713 35152404 35162296 
Adora2a adenosine A2a receptor (Adora2a) [NM_009630] 3 74811436 74812183 74766682 74768072 
Adra1a adrenergic receptor, alpha 1a (Adra1a) [NM_013461] 4.7 67326057 67326796 67253722 67257789 
Agap2 
ArfGAP with GTPase domain, ankyrin repeat and PH 
domain 2 (Agap2) [NM_001033263] 
248.9 126511962 126513078 126511826 126523218 
Agtr1a 
angiotensin II receptor, type 1a (Agtr1a) 
[NM_177322] 
37.7 30431640 30432259 30426387 30427318 
Agxt2l1 
alanine-glyoxylate aminotransferase 2–like 1 
(Agxt2l1),   [NM_027907] 
2.8 130240502 130241157 130319828 130321096 
Ajap1 
adherens junction associated protein 1 (Ajap1) 
[NM_001099299] 
236.6 152828273 152829100 152860367 152864210 
Aldh1a3 
aldehyde dehydrogenase family 1, subfamily A3 
(Aldh1a3) [NM_053080] 
11.1 73659237 73659977 73571152 73574988 
Alk anaplastic lymphoma kinase 3.7 73011067 73011737 72951844 72954641 
Ambra1 
autophagy/beclin 1 regulator 1 (Ambra1),   
[NM_172669] 
2.5 91612175 91613104 91612325 91614178 
Amfr 
autocrine motility factor receptor (Amfr) 
[NM_011787] 
4.4 96547791 96548361 96496004 96499340 
Amz1 
archaelysin family metallopeptidase 1 (Amz1) 
[NM_173405] 
7.1 141234507 141237202 141218947 141221387 
Ank1 ankyrin 1, erythroid (Ank1),   [NM_031158] 4.5 24114223 24115251 24087878 24089725 
Ank3 ankyrin 3, epithelial (Ank3),   [NM_146005] 11.2 69074432 69075199 68961340 68962442 
Ankrd13a ankyrin repeat domain 13a (Ankrd13a) [NM_026718] 2.3 115206985 115208253 115211903 115213547 
Ankrd44 ankyrin repeat domain 44 3.7 54995259 54995957 54924791 54925936 
Anp32a 
acidic (leucine-rich) nuclear phosphoprotein 32 
family, member A (Anp32a) [NM_009672] 
2.5 62163331 62164009 62194574 62198289 
Antxr1 anthrax toxin receptor 1 (Antxr1) [NM_054041] 3.5 87277754 87278579 87276656 87279278 
Anxa3 annexin A3 (Anxa3) [NM_013470] 2.2 97241590 97242268 97196666 97197675 
Aox1 aldehyde oxidase 1 (Aox1) [NM_009676] 34 58081166 58081703 58111530 58112869 
Ap2s1 
adaptor-related protein complex 2, sigma 1 subunit 
(Ap2s1) [NM_198613] 
3.5 17332099 17334982 17325884 17331369 
Ap3b2 
adaptor-related protein complex 3, beta 2 subunit 
(Ap3b2) [NM_021492] 
488.9 88639909 88641241 88628780 88630699 
Ap3d1 
adaptor-related protein complex 3, delta 1 subunit 
(Ap3d1) [NM_007460] 
247.7 80195050 80196513 80189143 80194171 
Apob apolipoprotein B (Apob) [NM_009693] 4.7 7994867 7995900 8068552 8069828 
Apol8 apolipoprotein L 8 85.1 77582741 77584070 77582767 77584858 
Aqp12 aquaporin 12 (Aqp12),   [NM_177587] 5.4 94930097 94932003 94927326 94934262 
Arf1 ADP-ribosylation factor 1 (Arf1),   [NM_007476] 2.2 59065665 59066434 59050447 59059539 
Arhgap20 
Rho GTPase activating protein 20 (Arhgap20) 
[NM_175535] 
66.1 51504719 51505324 51572515 51575490 
Arhgef7 
Rho guanine nucleotide exchange factor (GEF7) 
(Arhgef7),   [NM_001113517] 
9.9 11746678 11748148 11729934 11731640 
Arx aristaless related homeobox (Arx) [NM_007492] 3.3 90629174 90629640 90530192 90536461 
Atf1 activating transcription factor 1 (Atf1) [NM_007497] 2 100009921 100011245 100012144 100013726 
Atp12a ATPase, H/K transporting, nongastric, alpha 177.1 56948986 56949621 56967874 56969530 
polypeptide (Atp12a) [NM_138652] 
Atp1a2 
ATPase, Na/K transporting, alpha 2 polypeptide 
(Atp1a2) [NM_178405] 
31.7 174215183 174216559 174228984 174232036 
Atp2b1 
ATPase, Ca+ transporting, plasma membrane 1 
(Atp2b1) [NM_026482] 
2.2 98464762 98465396 98199991 98201125 
AW554918 
expressed sequence AW554918 (AW554918) 
[NM_001033532] 
2.4 25276175 25276980 25177026 25177956 
B230206H07Rik 
RIKEN cDNA B230206H07 gene (B230206H07Rik), 
non-coding RNA [NR_033532] 
25.4 148540503 148542216 148540344 148544615 
B3gat2 
beta-1,3-glucuronyltransferase 2 
(glucuronosyltransferase S) (B3gat2) [NM_172124] 
5.3 23773502 23774309 23767388 23771402 
BC018507 cDNA sequence BC018507 (BC018507) [NM_144837] 4.2 70686081 70686844 70741015 70745284 
BC051665 cDNA sequence BC051665 (BC051665) [NM_199148] 21.4 60853246 60854165 60861555 60863611 
Brap BRCA1-associated protein (Brap) [NM_028227] 2.3 122116137 122116861 122126705 122127577 
Brms1l 
breast cancer metastasis-suppressor 1-like (Brms1l) 
[NM_001037756] 
5.5 56941393 56941929 56961074 56962599 
Bves 
blood vessel epicardial substance (Bves) 
[NM_024285] 
7.1 45071163 45072319 45054060 45056212 
C030034L19Rik RIKEN cDNA C030034L19 gene 3.3 9450459 9451109 9431918 9433424 
C130022K22Rik 
RIKEN cDNA C130022K22 gene (C130022K22Rik) 
[NM_172730] 
2.8 91815338 91816125 91812562 91816568 
C1ql2 
complement component 1, q subcomponent–like 2 
(C1ql2) [NM_207233] 
3.8 122278908 122279671 122234088 122240580 
C1qtnf9 
C1q and tumor necrosis factor–related protein 9 
(C1qtnf9) [NM_183175] 
11.1 61379361 61381649 61383482 61386250 
C2cd4b 
C2 calcium-dependent domain containing 4B 
(C2cd4b) [NM_001081314] 
24.1 67517459 67518828 67606625 67609182 
C8b 
complement component 8, beta polypeptide (C8b) 
[NM_133882] 
28.4 104445025 104445790 104433442 104434707 
Cacng1 
calcium channel, voltage-dependent, gamma subunit 
1 (Cacng1) [NM_007582] 
3.4 107585222 107586059 107564348 107568533 
Cacng8 
calcium channel, voltage-dependent, gamma subunit 
8 (Cacng8) [NM_133190] 
12.2 3368691 3369298 3364555 3367964 
Calcr calcitonin receptor (Calcr),  b [NM_007588] 9.4 3713254 3714814 3713068 3714926 
Cartpt CART prepropeptide (Cartpt),   [NM_013732] 2.1 100715390 100716040 100668533 100671536 
Casc1 cancer susceptibility candidate 1 2.8 145144930 145145695 145153407 145154461 
Cbr4 carbonyl reductase 4 (Cbr4) [NM_145595] 5.7 64043033 64043783 63937548 63940073 
Ccbe1 
collagen and calcium binding EGF domains 1 (Ccbe1) 
[NM_178793] 
2.1 66523434 66524483 66502971 66503954 
Ccdc90a 
coiled-coil domain containing 90A (Ccdc90a) 
[NM_001081059] 
56.1 43644896 43645907 43666384 43668002 
Cd93 CD93 antigen (Cd93) [NM_010740] 4.1 148275308 148275952 148266593 148269840 
Cdc7 
cell division cycle 7 (S. cerevisiae) (Cdc7) 
[NM_009863] 
2.3 107484048 107484897 107431942 107433569 
Cdca7l 
cell division cycle–associated 7 like (Cdca7l) 
[NM_146040] 
10.6 118974676 118975352 119008545 119010548 
Cdh4 cadherin 4 (Cdh4) [NM_009867] 4.2 179203401 179205682 179174839 179180146 
Cdkal1 
CDK5 regulatory subunit associated protein 1–like 1 
(Cdkal1) [NM_144536] 
4.4 29925470 29926121 29794265 29795233 
Cdon 
cell adhesion molecule-related/down-regulated by 
oncogenes (Cdon) [NM_021339] 
3.3 35216184 35216898 35220568 35221663 
Cdyl2 
chromodomain protein, Y chromosome–like 2 
(Cdyl2) [NM_029441] 
3.3 119262013 119262804 119173633 119175303 
Ceacam19 
carcinoembryonic antigen-related cell adhesion 
molecule 19 (Ceacam19) [NM_177036] 
6.5 20462795 20464540 20461980 20464753 
Cenpf centromere protein F (Cenpf) [NM_001081363] 2.2 191509464 191510229 191503124 191504092 
Cfi complement component factor i (Cfi) [NM_007686] 160.6 129552535 129553190 129550224 129551018 
Chgb chromogranin B (Chgb) [NM_007694] 5.2 132590732 132591513 132606618 132608242 
Chmp2b 
charged multivesicular body protein 2B (Chmp2b) 
[NM_026879] 
2.1 65544952 65545623 65571578 65573518 
Chordc1 
cysteine and histidine-rich domain (CHORD)-
containing, zinc-binding protein 1 (Chordc1) 
[NM_025844] 
6.4 18104353 18105271 18061695 18062878 
Chst12 
carbohydrate sulfotransferase 12 (Chst12) 
[NM_021528] 
3.1 140964970 140966161 140968380 140970431 
Ckmt2 
creatine kinase, mitochondrial 2 (Ckmt2), nuclear 
gene encoding mitochondrial protein [NM_198415] 
227.5 92028986 92030308 92048170 92050072 
Clec16a 
C-type lectin domain family 16, member A (Clec16a),   
[NM_177562] 
5.9 10609925 10611544 10609803 10611867 
Clic6 
chloride intracellular channel 6 (Clic6), nuclear gene 
encoding mitochondrial protein [NM_172469] 
2.6 92524818 92526178 92497451 92500215 
Cln8 ceroid-lipofuscinosis, neuronal 8 (Cln8) [NM_012000] 3.6 14838933 14840129 14839039 14840931 
Clybl citrate lyase beta like (Clybl) [NM_029556] 24.8 122632308 122633329 122570818 122572191 
Cnksr3 Cnksr family member 3 (Cnksr3) [NM_172546] 6.6 3082532 3083144 3150511 3151976 
Cnr1 cannabinoid receptor 1 (brain) (Cnr1) [NM_007726] 2.3 34030786 34032028 33994635 33995767 
Cntn3 contactin 3 (Cntn3) [NM_008779] 2.4 102347283 102347929 102513536 102514888 
Cog2 component of oligomeric Golgi complex 2 (Cog2) 2.9 127022129 127022902 127034487 127035569 
[NM_029746] 
Cog6 
component of oligomeric Golgi complex 6 (Cog6) 
[NM_026225] 
2.9 52756565 52757205 52802557 52803626 
Cog7 
component of oligomeric Golgi complex 7 (Cog7) 
[NM_001033318] 
2.8 129094610 129095548 129143257 129144577 
Col13a1 collagen, type XIII, alpha 1 (Col13a1) [NM_007731] 12 61418621 61420135 61435861 61443604 
Col14a1 collagen, type XIV, alpha 1 (Col14a1) [NM_181277] 20.1 55185084 55185863 55137772 55141026 
Corin corin (Corin),   [NM_016869] 25.1 72911176 72911830 72893988 72896415 
Cpn2 
carboxypeptidase N, polypeptide 2 (Cpn2) 
[NM_027904] 
137.6 30265239 30266075 30256568 30261523 
Cryz crystallin, zeta (Cryz) [NM_009968] 4.9 154243017 154243626 154210360 154211601 
Ctdp1 
CTD (C-terminal domain, RNA polymerase II, 
polypeptide A) phosphatase, subunit 1 (Ctdp1) 
[NM_026295] 
25 80673132 80674222 80687731 80689822 
Ctnnd2 
catenin (cadherin-associated protein), delta 2 
(Ctnnd2) [NM_008729] 
6.2 30143203 30144130 30101375 30104103 
Cttn cortactin (Cttn),   [NM_007803] 3.2 151661814 151662852 151685467 151688252 
Cutc 
cutC copper transporter homolog (E. coli) (Cutc),   
[NM_025530] 
2.2 43813760 43815051 43808161 43809621 
Cwc15 CWC15 homolog (S. cerevisiae) 5.8 14337063 14338038 14359806 14363422 
Cxcl12 
chemokine (C-X-C motif) ligand 12 (Cxcl12),   
[NM_001012477] 
3.5 117099526 117100316 117115608 117120445 
Cyb5b 
cytochrome b5 type B (Cyb5b), nuclear gene 
encoding mitochondrial protein [NM_025558] 
70.8 109677019 109678238 109728409 109730754 
Cybrd1 cytochrome b reductase 1 (Cybrd1) [NM_028593] 5.1 70983557 70984457 70981996 70984566 
Cyp19a1 
cytochrome P450, family 19, subfamily a, 
polypeptide 1 (Cyp19a1) [NM_007810] 
347.4 54123560 54124297 54117520 54119036 
Cyp2d22 
cytochrome P450, family 2, subfamily d, polypeptide 
22 (Cyp2d22),   [NM_001163472] 
2.4 82201202 82202492 82202769 82205394 
Cyp2d34 
cytochrome P450, family 2, subfamily d, polypeptide 
34 (Cyp2d34) [NM_145474] 
18.7 82467890 82468596 82467079 82468837 
Cyp2d9 
cytochrome P450, family 2, subfamily d, polypeptide 
9 (Cyp2d9) [NM_010006] 
5.3 82293841 82294608 82271331 82273179 
Cyp4f15 
cytochrome P450, family 4, subfamily f, polypeptide 
15 (Cyp4f15) [NM_134127] 
2.4 32812210 32813491 32812335 32813859 
D030016E14Rik 
RIKEN cDNA D030016E14 gene (D030016E14Rik) 
[NM_177240] 
325.4 48602856 48603637 48590517 48591751 
D10Wsu102e 
DNA segment, Chr 10, Wayne State University 102, 
expressed (D10Wsu102e) [NM_026579] 
2.9 82867774 82868986 82867602 82868637 
D1Pas1 
DNA segment, Chr 1, Pasteur Institute 1 (D1Pas1) 
[NM_033077] 
2 188776272 188777281 188809717 188810850 
D3Bwg0562e 
DNA segment, Chr 3, Brigham & Women's Genetics 
0562 expressed (D3Bwg0562e) [NM_177664] 
41 117062581 117063640 117062406 117064002 
D6Wsu163e 
DNA segment, Chr 6, Wayne State University 163, 
expressed 
5.8 126892081 126893185 126902043 126904143 
Daam2 
dishevelled associated activator of morphogenesis 2 
(Daam2) [NM_001008231] 
4.7 49684920 49685951 49701309 49704335 
Dab1 
disabled homolog 1 (Drosophila) (Dab1),   
[NM_177259] 
3.5 103350573 103351235 103291416 103294850 
Dact2 
dapper homolog 2, antagonist of beta-catenin 
(Xenopus) (Dact2) [NM_172826] 
2.2 14312879 14313924 14332072 14335590 
Daglb diacylglycerol lipase, beta 15 144255269 144255881 144247629 144251414 
Dao D-amino acid oxidase (Dao) [NM_010018] 4.3 114459657 114460264 114457662 114458898 
Dcaf12l2 
DDB1 and CUL4 associated factor 12–ike 2 (Dcaf12l2) 
[NM_175539] 
4.5 41726488 41726946 41720324 41722088 
Dclre1a 
DNA cross-link repair 1A, PSO2 homolog (S. 
cerevisiae) (Dclre1a) [NM_018831] 
2.1 56601784 56602327 56611934 56612796 
Dcp1a 
DCP1 decapping enzyme homolog A (S. cerevisiae) 
(Dcp1a) [NM_133761] 
9.3 31220319 31221039 31166631 31168523 
Ddo D-aspartate oxidase (Ddo) [NM_027442] 58.6 40327973 40328676 40349692 40351899 
Dhrs7c 
dehydrogenase/reductase (SDR family) member 7C 
(Dhrs7c) [NM_001013013] 
11.1 67629030 67630007 67627501 67629907 
Dhtkd1 
dehydrogenase E1 and transketolase domain 
containing 1 
3.8 5853060 5853953 5848197 5851089 
Dhx15 
DEAH (Asp-Glu-Ala-His) box polypeptide 15 (Dhx15),   
[NM_007839] 
2.7 52492375 52493572 52519619 52520751 
Dio3os 
deiodinase, iodothyronine type III, opposite strand 
(Dio3os), non-coding RNA [NR_002866] 
128.5 111481076 111482560 111512540 111521526 
Dirc2 
disrupted in renal carcinoma 2 (human) (Dirc2) 
[NM_153550] 
2.8 35763802 35764494 35749125 35750301 
Dlk1 delta-like 1 homolog (Drosophila) 16.3 110697606 110698629 110690011 110699920 
Dmrt2 
doublesex and mab-3 related transcription factor 2 
(Dmrt2) [NM_145831] 
41.7 25735078 25735740 25724174 25725445 
Dmrt3 
doublesex and mab-3 related transcription factor 3 
(Dmrt3) [NM_177360] 
3.3 25712535 25713239 25689401 25690588 
Dock4 dedicator of cytokinesis 4 (Dock4) [NM_172803] 11.4 41255227 41255892 41225286 41226753 
Dock5 dedicator of cytokinesis 5 (Dock5) [NM_177780] 103.7 68593078 68593625 68569101 68570132 
Dpf3 
D4, zinc and double PHD fingers, family 3 (Dpf3) 
[NM_058212] 
7.2 84432221 84433547 84441161 84444461 
Dpysl3 dihydropyrimidinase-like 3 (Dpysl3),   [NM_009468] 2.6 43613083 43613553 43596761 43598667 
Dtx1 deltex 1 homolog (Drosophila) (Dtx1) [NM_008052] 2.3 121172131 121172947 121168645 121171409 
Dusp26 
dual specificity phosphatase 26 (putative) (Dusp26) 
[NM_025869] 
9.3 32144360 32145495 32198334 32202891 
Dync1i1 
dynein cytoplasmic 1 intermediate chain 1 (Dync1i1),   
[NM_010063] 
67.3 5683181 5683938 5675465 5676737 
E130203B14Rik 
RIKEN cDNA E130203B14 gene (E130203B14Rik) 
[NM_178791] 
5.5 33682521 33683419 33671171 33675274 
E2f6 E2F transcription factor 6 (E2f6),   [NM_033270] 2.6 16828581 16829921 16831444 16832670 
Ebf3 early B-cell factor 3 (Ebf3),   [NM_010096] 2.8 144495309 144496028 144500235 144502964 
Eepd1 
endonuclease/exonuclease/phosphatase family 
domain containing 1 (Eepd1) [NM_026189] 
5.7 25294873 25295942 25183958 25186420 
Efna5 ephrin A5 (Efna5),   [NM_010109] 2.4 62971932 62972586 63275746 63277334 
Efnb2 ephrin B2 (Efnb2) [NM_010111] 2.1 8583574 8584431 8576063 8577627 
Ehd3 EH-domain containing 3 (Ehd3) [NM_020578] 306.9 74148635 74149444 74153492 74155306 
Eif2ak4 
eukaryotic translation initiation factor 2 alpha kinase 
4 (Eif2ak4),   [NM_013719] 
9.1 118233731 118234519 118233068 118234731 
Eif2s2 
eukaryotic translation initiation factor 2, subunit 2 
(beta) (Eif2s2) [NM_026030] 
5.2 154750435 154751031 154766880 154769061 
Eif4g2 
eukaryotic translation initiation factor 4, gamma 2 
(Eif4g2),   [NM_013507] 
5.2 118317135 118318392 118353426 118356815 
Elovl5 
ELOVL family member 5, elongation of long chain 
fatty acids (yeast) (Elovl5) [NM_134255] 
30.5 77733902 77734540 77771344 77772606 
Eml4 
echinoderm microtubule associated protein like 4 
(Eml4),   [NM_199466] 
7.1 83801565 83802967 83801718 83802865 
Emr1 
EGF-like module containing, mucin-like, hormone 
receptor–like sequence 1 (Emr1) [NM_010130] 
5.1 57559259 57560072 57483307 57484654 
Emx2 
empty spiracles homolog 2 (Drosophila) (Emx2) 
[NM_010132] 
2 59610969 59611504 59541418 59547500 
En2 engrailed 2 (En2) [NM_010134] 189.5 28484078 28486270 28481211 28488209 
Enpep glutamyl aminopeptidase (Enpep) [NM_007934] 18 129034175 129035102 129034285 129035969 
Epb4.1l2 
erythrocyte protein band 4.1-like 2 (Epb4.1l2),   
[NM_013511] 
4.3 25053949 25054854 25154141 25155133 
Epb4.1l3 erythrocyte protein band 4.1-like 3 3 69448130 69449437 69456776 69458413 
Epb4.1l4a 
erythrocyte protein band 4.1-like 4a (Epb4.1l4a) 
[NM_013512] 
139.6 34132656 34133232 34145201 34148943 
Esd 
esterase D/formylglutathione hydrolase (Esd) 
[NM_016903] 
11.9 75154806 75155736 75117393 75118826 
Exoc6 exocyst complex component 6 7.4 37641605 37642303 37643554 37644547 
Eya1 
eyes absent 1 homolog (Drosophila) (Eya1),   
[NM_010164] 
2.6 14358181 14358709 14269082 14270000 
Eya4 eyes absent 4 homolog (Drosophila) 14.5 23010080 23010634 23067603 23070902 
Fabp1 
fatty acid–binding protein 1, liver (Fabp1) 
[NM_017399] 
13.1 71166592 71167421 71147233 71149277 
Fads2 fatty acid desaturase 2 (Fads2) [NM_019699] 2.2 10202221 10202877 10174289 10177255 
Fam123a 
family with sequence similarity 123, member A 
(Fam123a),   [NM_028113] 
2.5 60940404 60941073 60995935 60999444 
Fam13c 
family with sequence similarity 13, member C 
(Fam13c),   [NM_024244] 
2.1 69915365 69915978 69913619 69914682 
Fam161b 
family with sequence similarity 161, member B 
(Fam161b) [NM_172581] 
28.2 85713821 85714727 85711867 85714774 
Fam168b 
family with sequence similarity 168, member B 
(Fam168b),   [NM_174997] 
2.9 34874041 34875605 34879765 34881931 
Fam46c 
family with sequence similarity 46, member C 
(Fam46c) [NM_001142952] 
24.4 100273078 100273897 100275638 100277848 
Fam53a 
family with sequence similarity 53, member A 
(Fam53a) [NM_178390] 
2.4 33967496 33968596 33954329 33956309 
Fam76a 
family with sequence similarity 76, member A 
(Fam76a),   [NM_145553] 
2.2 132467943 132469029 132459804 132461821 
Far1 fatty acyl CoA reductase 1 4.4 120649689 120650486 120649807 120650730 
Fat3 
FAT tumor suppressor homolog 3 (Drosophila) (Fat3) 
[NM_001080814] 
123.6 16122213 16122902 16128450 16129617 
Fbxl17 
F-box and leucine-rich repeat protein 17 (Fbxl17) 
[NM_015794] 
6.9 63881495 63882060 63772994 63774019 
Fbxl22 
F-box and leucine-rich repeat protein 22 (Fbxl22) 
[NM_175206] 
7.6 66307520 66308341 66351473 66353912 
Fbxo10 F-box protein 10 (Fbxo10) [NM_001024142] 97.8 45090369 45091208 45084181 45085647 
Fer1l4 fer-1–like 4 (C. elegans) (Fer1l4) [NM_001136556] 3.3 155862521 155863473 155867863 155875932 
Fez1 fasciculation and elongation protein zeta 1 (zygin I) 2.2 36672756 36673308 36639755 36642362 
Ffar2 free fatty acid receptor 2 (Ffar2),   [NM_146187] 197.3 31614394 31615194 31617204 31618194 
Fgf5 fibroblast growth factor 5 (Fgf5) [NM_010203] 67.3 98703007 98703809 98684254 98685884 
Fgf7 fibroblast growth factor 7 (Fgf7) [NM_008008] 12.5 125800809 125801659 125854461 125855509 
Fgfr2 
fibroblast growth factor receptor 2 (Fgfr2),   
[NM_010207] 
6.1 140244618 140245749 140260858 140264353 
Fgg fibrinogen gamma chain (Fgg) [NM_133862] 133.5 82816301 82817057 82798474 82800174 
Fignl1 fidgetin-like 1 (Fignl1),   [NM_021891] 4.5 11685597 11686692 11676316 11677899 
Flt1 FMS-like tyrosine kinase 1 8.7 148441802 148443646 148536080 148539631 
Fndc1 
fibronectin type III domain containing 1 (Fndc1) 
[NM_001081416] 
2.1 7963942 7965415 8017678 8021460 
Fndc3c1 
fibronectin type III domain containing 3C1 (Fndc3c1) 
[NM_001007580] 
44.1 103704651 103705485 103680247 103681824 
Foxc1 forkhead box C1 (Foxc1) [NM_008592] 7.6 31931485 31932573 31897160 31900990 
Foxp2 forkhead box P2 (Foxp2),   [NM_053242] 2.4 14781006 14781545 14847899 14852567 
Fras1 
Fraser syndrome 1 homolog (human) (Fras1) 
[NM_175473] 
2.2 96776911 96777726 96867388 96869253 
Frmd6 FERM domain containing 6 (Frmd6) [NM_028127] 3.5 71865200 71865693 71978532 71980073 
Frmpd3 
FERM and PDZ domain containing 3 (Frmpd3) 
[NM_177750] 
2 136940795 136941515 136876324 136877842 
Ftcd 
formiminotransferase cyclodeaminase (Ftcd) 
[NM_080845] 
8.7 76043682 76044823 76037615 76040120 
Fth1 ferritin heavy chain 1 (Fth1) [NM_010239] 2.6 10045629 10046267 10028630 10029974 
Fzd5 
frizzled homolog 5 (Drosophila) (Fzd5),   
[NM_022721] 
169.7 64790734 64791806 64835737 64838617 
Gap43 growth associated protein 43 (Gap43) [NM_008083] 4.6 42371712 42372773 42291701 42292758 
Gcap14 
granule cell antiserum positive 14 (Gcap14),   
[NM_027045] 
2.6 37799652 37800232 37787539 37788428 
Gdf10 
growth differentiation factor 10 (Gdf10) 
[NM_145741] 
264.5 34727870 34728822 34735754 34739801 
Ggnbp1 gametogenetin-binding protein 1 8.7 27123211 27124686 27124988 27126470 
Gja8 gap junction protein, alpha 8 (Gja8) [NM_008123] 3.9 96733623 96735186 96722522 96724563 
Gli3 GLI-Kruppel family member GLI3 (Gli3) [NM_008130] 3.1 15471609 15472464 15494123 15495767 
Gm12824 predicted gene 12824 (Gm12824) [NM_001085549] 62.1 114149735 114151297 114077993 114080364 
Gm16532 predicted gene, 16532 (Gm16532) [NM_001134752] 2.7 6376965 6378458 6367308 6368886 
Gm608 predicted gene 608 (Gm608) [NM_001029889] 8 44188670 44189320 44218289 44220169 
Gm9725 predicted gene 9725 3.6 83509006 83510432 83509359 83510823 
Gmpr 
guanosine monophosphate reductase (Gmpr) 
[NM_025508] 
18.9 45687147 45687983 45610018 45612918 
Got1 
glutamate oxaloacetate transaminase 1, soluble 
(Got1) [NM_010324] 
19.7 43578850 43580519 43578258 43580563 
Got2 
glutamate oxaloacetate transaminase 2, 
mitochondrial (Got2), nuclear gene encoding 
mitochondrial protein [NM_010325] 
6.4 98447328 98448179 98431423 98433231 
Gprc5b 
G protein–coupled receptor, family C, group 5, 
member B (Gprc5b),   [NM_022420] 
6.9 126147152 126148348 126153522 126156515 
Grem2 
gremlin 2 homolog, cysteine knot superfamily 
(Xenopus laevis) (Grem2) [NM_011825] 
3.2 176847002 176847697 176851288 176852334 
Gria1 
glutamate receptor, ionotropic, AMPA1 (alpha 1) 
(Gria1),   [NM_008165] 
4.2 56823863 56824708 56824380 56825801 
Grik4 
glutamate receptor, ionotropic, kainate 4 (Grik4) 
[NM_175481] 
3.6 42798533 42799104 42757679 42759815 
Gsdmc gasdermin C (Gsdmc) [NM_031378] 2 63579928 63580597 63527330 63528145 
Gstm4 
glutathione S-transferase, mu 4 (Gstm4),   
[NM_026764] 
4.9 107854243 107854753 107864574 107866436 
Gtl3 gene trap locus 3 (Gtl3) [NM_008187] 2.8 97970049 97971667 97934524 97936098 
Gucy1b3 
guanylate cyclase 1, soluble, beta 3 (Gucy1b3),   
[NM_017469] 
4.1 81868751 81869356 81877314 81879142 
Gypc glycophorin C (Gypc) [NM_001048207] 23.8 32702088 32704674 32690768 32692830 
Hacl1 2-hydroxyacyl-CoA lyase 1 (Hacl1) [NM_019975] 4 32507537 32508222 32466193 32467519 
Haus4 
HAUS augmin-like complex, subunit 4 (Haus4) 
[NM_145462] 
2.3 55162348 55163437 55162093 55163987 
Hcfc1 host cell factor C1 (Hcfc1) [NM_008224] 3 71209501 71210509 71192416 71196314 
Hdgfrp3 
hepatoma-derived growth factor, related protein 3 
(Hdgfrp3) [NM_013886] 
17.3 89052416 89053205 89052101 89053290 
Hif1an 
hypoxia-inducible factor 1, alpha subunit inhibitor 
(Hif1an) [NM_176958] 
3.8 44675593 44676812 44645343 44651562 
Hmgb4 high-mobility group box 4 (Hmgb4) [NM_027036] 117.2 127927410 127929302 127927511 127929291 
Hn1l hematological and neurological expressed 1-like 6.4 25123815 25125476 25118794 25120892 
Hpd 
4-hydroxyphenylpyruvic acid dioxygenase (Hpd) 
[NM_008277] 
7.2 123651473 123652482 123630110 123633222 
Hs3st2 
heparan sulfate (glucosamine) 3-O-sulfotransferase 2 
(Hs3st2) [NM_001081327] 
257.4 128540756 128541586 128534503 128537429 
Htr4 
5 hydroxytryptamine (serotonin) receptor 4 (Htr4) 
[NM_008313] 
3.4 62544087 62544922 62482490 62485360 
Htr7 
5-hydroxytryptamine (serotonin) receptor 7 (Htr7) 
[NM_008315] 
3.2 36076825 36077881 36130795 36132801 
Ido2 indoleamine 2,3-dioxygenase 2 (Ido2) [NM_145949] 125.3 25671104 25672057 25655607 25658393 
Igf1r 
insulin-like growth factor I receptor (Igf1r) 
[NM_010513] 
3.6 75052750 75053930 75066616 75067918 
Igfbp2 
insulin-like growth factor–binding protein 2 (Igfbp2) 
[NM_008342] 
2.3 72831487 72832327 72859492 72860930 
Igfbp5 
insulin-like growth factor–binding protein 5 (Igfbp5) 
[NM_010518] 
2.6 72902175 72904233 72901792 72904275 
Igfbp7 
insulin-like growth factor–binding protein 7 (Igfbp7),   
[NM_008048] 
2.4 77845732 77846543 77836199 77837534 
Igsf3 
immunoglobulin superfamily, member 3 (Igsf3) 
[NM_207205] 
9.2 101229171 101230573 101167051 101167990 
Ikzf1 
IKAROS family zinc finger 1 (Ikzf1),   
[NM_001025597] 
2.6 11576327 11577006 11583999 11586982 
Il20rb interleukin 20 receptor beta 3.1 100321309 100322281 100347806 100351652 
Inhbb inhibin beta-B (Inhbb) [NM_008381] 6 121220753 121221963 121312397 121323426 
Irx1 
Iroquois related homeobox 1 (Drosophila) (Irx1) 
[NM_010573] 
2.4 72008261 72008897 72137243 72138356 
Itpr1 
inositol 1,4,5-trisphosphate receptor 1 (Itpr1) 
[NM_010585] 
5.6 108253257 108254218 108185448 108186597 
Jakmip3 
janus kinase and microtubule interacting protein 3 
(Jakmip3) [NM_028708] 
4.5 146147128 146148073 146130329 146134292 
Jam2 junction adhesion molecule 2 (Jam2) [NM_023844] 2.4 84766817 84767863 84773436 84775983 
Jazf1 JAZF zinc finger 1 (Jazf1),   [NM_001168277] 4.4 53009608 53010264 53045518 53047507 
Jmjd1c 
jumonji domain containing 1C (Jmjd1c),   
[NM_001242396] 
11.4 66486706 66487641 66501285 66502703 
Kalrn kalirin, RhoGEF kinase 8.2 34513770 34514770 34571523 34575143 
Kank4 
KN motif and ankyrin repeat domains 4 (Kank4) 
[NM_172872] 
2.1 98478472 98479270 98481626 98484986 
Kcnh1 
potassium voltage-gated channel, subfamily H (eag-
related), member 1 (Kcnh1),   [NM_010600] 
2.2 194089626 194091535 194013224 194016061 
Kcnq1 
potassium voltage-gated channel, subfamily Q, 
member 1 (Kcnq1) [NM_008434] 
13.6 150345362 150346725 150290962 150299164 
Kidins220 kinase D-interacting substrate 220 3.7 25623851 25624750 25625601 25628354 
Kin 
antigenic determinant of rec-A protein (Kin) 
[NM_025280] 
6 10011737 10012497 10020916 10022905 
Kl klotho (Kl) [NM_013823] 2.1 151822790 151824028 151753829 151756806 
Klc1 
kinesin light chain 1 (Klc1), transcript variant a 
[NM_008450] 
2.8 113011867 113013700 112999760 113003044 
Klk15 Kallikrein-related peptidase 15 (Klk15) [NM_174865] 2.3 51189829 51190740 51182531 51184298 
L2hgdh 
L-2-hydroxyglutarate dehydrogenase (L2hgdh), 
nuclear gene encoding mitochondrial protein 
[NM_145443] 
4.7 70805162 70805851 70804264 70805780 
L3mbtl4 l(3)mbt-like 4 (Drosophila) (L3mbtl4) [NM_177278] 8.3 68565539 68566145 68622543 68624748 
Lca5 
Leber congenital amaurosis 5 (human) (Lca5),   
[NM_027448] 
49.9 83287417 83288485 83336354 83338232 
Ldb3 LIM domain–binding 3 (Ldb3),   [NM_001039076] 12.7 35384535 35386246 35383474 35388061 
Lect2 
leukocyte cell–derived chemotaxin 2 (Lect2) 
[NM_010702] 
5.8 56650581 56651621 56639930 56641278 
Lepr leptin receptor (Lepr),   [NM_001122899] 3.5 101377837 101378416 101389624 101390924 
Lhx4 LIM homeobox protein 4 (Lhx4) [NM_010712] 7.6 157608115 157610195 157597261 157600966 
Lonrf2 LON peptidase N-terminal domain and ring finger 2 5.2 38876503 38877031 38892288 38894129 
Loxhd1 
lipoxygenase homology domains 1 (Loxhd1) 
[NM_172834] 
5.7 77530826 77532200 77546059 77548079 
Lpl lipoprotein lipase (Lpl) [NM_008509] 17.4 71398421 71399176 71439715 71440816 
Lrrc17 
leucine rich repeat–containing 17 (Lrrc17) 
[NM_028977] 
8.6 21037971 21039401 21052128 21053584 
Lypd1 Ly6/Plaur domain containing 1 (Lypd1) [NM_145100] 10.3 127859615 127860287 127806744 127810318 
Lysmd4 
LysM, putative peptidoglycan-binding, domain 
containing 4 (Lysmd4), transcript variant B 
[NM_175215] 
4.5 74402698 74403340 74370565 74374961 
Lyz1 lysozyme 1 (Lyz1) [NM_013590] 12.9 116733084 116733732 116760805 116761840 
Map2k6 mitogen-activated protein kinase kinase 6  179.2 110288160 110288852 110270122 110271403 
Mapk8ip3 
mitogen-activated protein kinase 8 interacting 
protein 3 
5.3 25066190 25067007 25060535 25062764 
Mbnl2 muscleblind-like 2 (Mbnl2),   [NM_175341] 10 120640871 120641782 120685157 120688978 
Me2 
malic enzyme 2, NAD(+)-dependent, mitochondrial 
(Me2), nuclear gene encoding mitochondrial protein 
[NM_145494] 
4.2 73950219 73950944 73964203 73966118 
Mef2a myocyte enhancer factor 2A 2.8 74611293 74612542 74603472 74610028 
Mobp 
myelin-associated oligodendrocytic basic protein 
(Mobp),   [NM_008614] 
2.4 120057913 120058888 120057823 120058204 
Mpp6 
membrane protein, palmitoylated 6 (MAGUK p55 
subfamily member 6) (Mpp6),   [NM_019939] 
14.7 50122416 50123001 50077025 50078009 
Mrps31 
mitochondrial ribosomal protein S31 (Mrps31), 
nuclear gene encoding mitochondrial protein 
[NM_020560] 
3.9 23540121 23541454 23538276 23539706 
Msi2 
Musashi homolog 2 (Drosophila) (Msi2) 
[NM_054043] 
337.3 88518467 88519509 88535906 88539975 
Mtr 
5-methyltetrahydrofolate-homocysteine 
methyltransferase (Mtr) [NM_001081128] 
2.5 12287214 12287912 12371967 12373022 
Mvk mevalonate kinase (Mvk) [NM_023556] 3.3 114944871 114945964 114913708 114918189 
Myh10 
myosin, heavy polypeptide 10, non-muscle (Myh10) 
[NM_175260] 
5.2 68515894 68516922 68504473 68507421 
Myh11 myosin, heavy polypeptide 11, smooth muscle 210 14256302 14257046 14247607 14249400 
(Myh11),   [NM_013607] 
Myo18b myosin XVIIIb (Myo18b) [NM_028901] 12.9 113274311 113275702 113323254 113325971 
Myof myoferlin (Myof) [NM_001099634] 5.2 38064418 38065072 37975240 37976374 
Myom2 myomesin 2 (Myom2) [NM_008664] 35.3 15071342 15072508 15062075 15064089 
Myoz2 myozenin 2 (Myoz2) [NM_021503] 45.3 122768849 122769657 122815157 122817559 
Mypn myopalladin (Mypn) [NM_182992] 2.9 62667818 62668290 62641843 62642874 
Myt1l 
myelin transcription factor 1-like (Myt1l),   
[NM_001093775] 
5.5 30227435 30228320 30217742 30218910 
N6amt1 
N-6 adenine-specific DNA methyltransferase 1 
(putative) (N6amt1),   [NM_026366] 
2 87344364 87344934 87364603 87365850 
Nceh1 
arylacetamide deacetylase-like 1 (Nceh1) 
[NM_178772] 
15.3 27083360 27084812 27140041 27141112 
Ndufa10 
NADH dehydrogenase (ubiquinone) 1 alpha 
subcomplex 10 (Ndufa10), nuclear gene encoding 
mitochondrial protein [NM_024197] 
28.3 94285435 94286312 94335874 94337883 
Ndufs4 
NADH dehydrogenase (ubiquinone) Fe-S protein 4 
(Ndufs4), nuclear gene encoding mitochondrial 
protein [NM_010887] 
4.3 115205499 115205968 115015936 115018014 
Nefl neurofilament, light polypeptide 114.4 68719694 68720653 68700553 68703583 
Neurl1a 
neuralized homolog 1A (Drosophila) (Neurl1a),   
[NM_021360] 
115.6 47340955 47343697 47272707 47278058 
Neurog3 neurogenin 3 (Neurog3) [NM_009719] 2.3 61597781 61598205 61598214 61601237 
Nhlrc2 NHL repeat containing 2 (Nhlrc2) [NM_025811] 2.3 56669000 56670066 56668860 56670686 
Nid2 nidogen 2 (Nid2) [NM_008695] 2.1 20565626 20566556 20569511 20572273 
Nnt 
nicotinamide nucleotide transhydrogenase (Nnt), 
nuclear gene encoding mitochondrial protein,   
[NM_008710] 
2.1 120115452 120116074 119974226 119975407 
Npas1 
neuronal PAS domain protein 1 (Npas1) 
[NM_008718] 
2.3 17102916 17103985 17069471 17071861 
Npffr1 
neuropeptide FF receptor 1 (Npffr1) 
[NM_001177511] 
2 61042759 61044727 61060244 61061792 
Nr2c1 
nuclear receptor subfamily 2, group C, member 1 
(Nr2c1) [NM_011629] 
42 93615075 93615782 93623712 93624921 
Nr5a1 nuclear receptor subfamily 5, group A, member 1 287.5 38585787 38586956 38573100 38577039 
Nsg1 
neuron specific gene family member 1 (Nsg1) 
[NM_010942] 
8.5 38565633 38567183 38555105 38559587 
Nt5dc3 
5'-nucleotidase domain containing 3 (Nt5dc3) 
[NM_175331] 
16.9 86257433 86258331 86258485 86259833 
Ntsr2 neurotensin receptor 2 (Ntsr2) [NM_008747] 120.7 16713871 16716406 16650161 16654444 
Nup133 nucleoporin 133 (Nup133) [NM_172288] 2.5 126458922 126459882 126480630 126487454 
Nxph3 neurexophilin 3 (Nxph3) [NM_130858] 2.2 95398542 95399698 95363289 95367036 
Olig2 
oligodendrocyte transcription factor 2 (Olig2) 
[NM_016967] 
256.5 91199887 91200861 91211585 91213042 
Oxa1l oxidase assembly 1-like (Oxa1l) [NM_026936] 3.1 55004266 55004743 54986095 54988697 
Pag1 
phosphoprotein associated with glycosphingolipid 
microdomains 1 (Pag1), transcript variant B 
[NM_053182] 
2.1 9861135 9862347 9861115 9862364 
Pah phenylalanine hydroxylase (Pah) [NM_008777] 525.8 87050656 87051277 86975737 86976803 
Papss1 
3'-phosphoadenosine 5'-phosphosulfate synthase 1 
(Papss1) [NM_011863] 
46.1 131264547 131265482 131275038 131277082 
Parp1 
poly (ADP-ribose) polymerase family, member 1 
(Parp1) [NM_007415] 
2.3 182532915 182533856 182489678 182490796 
Parp16 
poly (ADP-ribose) polymerase family, member 16 
(Parp16) [NM_177460] 
2.5 65077527 65078382 65055959 65057346 
Pax3 paired box gene 3 (Pax3),   [NM_008781] 2.2 78230394 78231211 78188737 78190820 
Pbx1 pre B cell leukemia homeobox 1 5.7 170284194 170285502 170229335 170230730 
Pccb 
propionyl Coenzyme A carboxylase, beta polypeptide 
(Pccb), nuclear gene encoding mitochondrial protein 
[NM_025835] 
169 100868046 100868925 100894207 100896938 
Pcmtd2 
protein-L-isoaspartate (D-aspartate) O-
methyltransferase domain containing 2 (Pcmtd2) 
[NM_153594] 
7.4 181545434 181546821 181554288 181555163 
Pdcd5 programmed cell death 5 (Pdcd5) [NM_019746] 2.2 36448760 36449940 36456491 36457533 
Pdcl3 phosducin-like 3 (Pdcl3) [NM_026850] 4.3 39021490 39022227 39072256 39073155 
Pde11a phosphodiesterase 11A 2.2 76164292 76164979 76175485 76178330 
Pdgfra 
platelet derived growth factor receptor, alpha 
polypeptide (Pdgfra),   [NM_011058] 
25.4 75623771 75624630 75548357 75553471 
Pdhx 
pyruvate dehydrogenase complex, component X 
(Pdhx), nuclear gene encoding mitochondrial protein 
[NM_175094] 
4 102862778 102863499 102891410 102892788 
Pdzrn3 
PDZ domain containing RING finger 3 (Pdzrn3) 
[NM_018884] 
2.3 101324609 101325326 101310422 101312243 
Peg10 paternally expressed 10 (Peg10),   [NM_001040611] 2 4703908 4705549 4703703 4705820 
Peg3 paternally expressed 3 15.5 6677467 6678649 6669622 6670215 
Pga5 pepsinogen 5, group I (Pga5) [NM_021453] 13.3 10733698 10734592 10743178 10751732 
Pgr progesterone receptor (Pgr) [NM_008829] 2.3 8842011 8842786 8899554 8902810 
Phactr3 phosphatase and actin regulator 3 (Phactr3),   49.3 177833783 177834478 177852099 177857713 
[NM_028806] 
Phf21b PHD finger protein 21B (Phf21b),   [NM_001081166] 84.6 84666055 84668729 84682658 84688580 
Pik3c2g 
phosphatidylinositol 3-kinase, C2 domain containing, 
gamma polypeptide (Pik3c2g),   [NM_207683] 
18.7 139566825 139567648 139669441 139670803 
Pip4k2a 
phosphatidylinositol-5-phosphate 4-kinase, type II, 
alpha (Pip4k2a) [NM_008845] 
38.7 18891866 18892415 18884656 18885826 
Pitx2 
paired-like homeodomain transcription factor 2 
(Pitx2),   [NM_001042502] 
31 128880209 128880726 128901178 128903879 
Pknox2 
Pbx/knotted 1 homeobox 2 (Pknox2),   
[NM_001029838] 
24.2 36921846 36922522 36951310 36956483 
Plcl2 phospholipase C–like 2 (Plcl2) [NM_013880] 10.6 50739579 50740357 50647198 50649781 
Plekha2 
pleckstrin homology domain-containing, family A 
(phosphoinositide binding specific) member 2 
(Plekha2) [NM_031257] 
2.5 26200876 26202097 26195153 26198150 
Plekhf1 
pleckstrin homology domain containing, family F 
(with FYVE domain) member 1 (Plekhf1) 
[NM_024413] 
2.5 39031317 39032390 39003471 39005901 
Plg plasminogen (Plg) [NM_008877] 135 12556846 12557685 12575610 12577448 
Pmaip1 
phorbol-12-myristate-13-acetate-induced protein 1 
(Pmaip1) [NM_021451] 
3.3 66659490 66660132 66564817 66565842 
Pmf1 polyamine-modulated factor 1 (Pmf1) [NM_025928] 3.2 88206045 88207671 88215151 88218284 
Pon1 paraoxonase 1 (Pon1) [NM_011134] 1400.9 5110007 5110666 5144250 5146366 
Ppa2 pyrophosphatase (inorganic) 2 5.6 132978635 132979414 132984079 132984966 
Ppap2a 
phosphatidic acid phosphatase type 2A (Ppap2a),   
[NM_008903] 
2.5 113606787 113607669 113625026 113625869 
Ppapdc1a 
phosphatidic acid phosphatase type 2 domain 
containing 1A (Ppapdc1a) [NM_001080963] 
2.8 136364401 136366122 136398747 136401897 
Ppm1a 
protein phosphatase 1A, magnesium dependent, 
alpha isoform (Ppm1a) [NM_008910] 
2.3 73908460 73908921 73929946 73934286 
Ppm1h 
protein phosphatase 1H (PP2C domain containing) 
(Ppm1h),   [NM_176919] 
2.7 122161096 122162033 122216165 122217917 
Ppp2r5c 
protein phosphatase 2, regulatory subunit B (B56), 
gamma isoform (Ppp2r5c),   [NM_012023] 
5.5 111717397 111718609 111695847 111697422 
Prdm15 PR domain containing 15 (Prdm15) [NM_144789] 3.2 98097628 98098250 98065976 98068422 
Prkcq protein kinase C, theta (Prkcq) [NM_008859] 2.9 11072294 11073133 11093493 11094542 
Prox1 prospero homeobox 1 117.1 192069048 192069954 191995614 192000125 
Prr18 proline rich region 18 (Prr18),   [NM_178774] 2.1 8520175 8521136 8531094 8537167 
Prrx2 paired related homeobox 2 3 30707710 30708812 30699093 30704729 
Psmd6 
proteasome (prosome, macropain) 26S subunit, non-
ATPase, 6 (Psmd6) [NM_025550] 
2.3 14927659 14928944 14931992 14933650 
Pvalb parvalbumin (Pvalb) [NM_013645] 21 78040416 78041912 78040353 78043272 
Rab3ip RAB3A interacting protein (Rab3ip) [NM_001003950] 6.1 116381938 116382679 116393943 116394870 
Rab43 
RAB43, member RAS oncogene family (Rab43),   
[NM_001039394] 
5.3 87750310 87751893 87770094 87772468 
Rap1b RAS related protein 1b (Rap1b) [NM_024457] 2.9 117340129 117340914 117258712 117259833 
Rasgef1b 
RasGEF domain family, member 1B (Rasgef1b),   
[NM_181318] 
11.7 99598648 99599693 99804041 99806482 
Rassf4 
Ras association (RalGDS/AF-6) domain family 
member 4 
3.1 116633279 116634085 116622954 116625633 
Rbfox1 
RNA-binding protein, fox-1 homolog (C. elegans) 1 
(Rbfox1),   [NM_021477] 
290.7 6861373 6862263 6348034 6349951 
Rbms3 
RNA-binding motif, single stranded interacting 
protein (Rbms3),   [NM_178660] 
3.8 117586506 117587301 117509630 117510430 
Rcan2 regulator of calcineurin 2 (Rcan2),   [NM_207649] 3 43986545 43987252 43937577 43939859 
Rchy1 
ring finger and CHY zinc finger domain–containing 1 
(Rchy1) [NM_026557] 
5.9 92320392 92320813 92199792 92200803 
Rcn3 
reticulocalbin 3, EF-hand calcium-binding domain 
(Rcn3) [NM_026555] 
7.5 52350373 52351075 52341212 52344521 
Rdh10 
retinol dehydrogenase 10 (all-trans) (Rdh10) 
[NM_133832] 
2.7 16136475 16137404 16167444 16168397 
Ret ret proto-oncogene (Ret),   [NM_009050] 2.2 118221375 118222141 118149621 118152069 
Rhbdl3 
rhomboid, veinlet-like 3 (Drosophila) (Rhbdl3) 
[NM_139228] 
2 80091602 80092224 80122723 80126866 
Ric8b 
resistance to inhibitors of cholinesterase 8 homolog 
B (C. elegans) (Ric8b),   [NM_001013441] 
6.3 84400715 84401682 84370425 84373553 
Rin2 Ras and Rab interactor 2 2.3 145592917 145593820 145569037 145570481 
Rnf157 ring finger protein 157 4.5 116267699 116268494 116272782 116275328 
Rnf165 ring finger protein 165 (Rnf165) [NM_001164504] 9.2 77713258 77714189 77801618 77805301 
Rnf32 ring finger protein 32 (Rnf32) [NM_021470] 13.9 29485634 29486214 29333554 29334854 
Rpap3 
RNA polymerase II associated protein 3 (Rpap3) 
[NM_028003] 
2.7 97533439 97534668 97542011 97546544 
Rpf1 
ribosome production factor 1 homolog (S. cerevisiae) 
(Rpf1),   [NM_027371] 
2.3 146193413 146194874 146195607 146196914 
Rps6kc1 
ribosomal protein S6 kinase polypeptide 1 (Rps6kc1) 
[NM_178775] 
45.9 192689782 192691355 192728036 192729421 
Rrm1 ribonucleotide reductase M1 (Rrm1) [NM_009103] 3.5 109553660 109554451 109578998 109580097 
Rwdd2a RWD domain containing 2A (Rwdd2a),   2.3 86476580 86477203 86483967 86485385 
[NM_027100] 
Rxfp2 
relaxin/insulin-like family peptide receptor 2 (Rxfp2) 
[NM_080468] 
8.6 150808271 150809049 150831399 150834326 
Rxrg retinoid X receptor gamma (Rxrg),   [NM_009107] 4.5 169521522 169522537 169527894 169530569 
Sacs sacsin 22.1 61770961 61772474 61752904 61754399 
Sall4 
sal-like 4 (Drosophila) (Sall4), transcript variant a 
[NM_175303] 
7.1 168597976 168599032 168593361 168596448 
Samd4 
sterile alpha motif domain containing 4 (Samd4),   
[NM_001037221] 
80.2 47540750 47542685 47514748 47516911 
Scaf4 
SR-related CTD-associated factor 4 (Scaf4) 
[NM_178923] 
163.8 90257532 90258555 90303225 90304465 
Scrn1 secernin 1 (Scrn1) [NM_027268] 124.3 54480848 54481914 54515265 54517194 
Sesn3 sestrin 3 (Sesn3) [NM_030261] 2.9 14036300 14036802 14039138 14040109 
Setd2 SET domain containing 2 (Setd2) [NM_001081340] 2.8 110428106 110428910 110421097 110422707 
Setd3 SET domain containing 3 (Setd3) [NM_028262] 3.7 109379727 109380645 109379723 109380639 
Sfrp2 
secreted frizzled-related protein 2 (Sfrp2) 
[NM_009144] 
2.9 83546186 83546894 83565426 83571568 
Sgcd 
sarcoglycan, delta (dystrophin-associated 
glycoprotein) (Sgcd) [NM_011891] 
4.1 47766766 47767550 47800643 47803327 
Shisa2 
shisa homolog 2 (Xenopus laevis) (Shisa2) 
[NM_145463] 
5.5 60236160 60237073 60243309 60247471 
Shisa9 
shisa homolog 9 (Xenopus laevis) (Shisa9),   
[NM_001174086] 
7 12052016 12052846 11982669 11989232 
Shq1 SHQ1 homolog (S. cerevisiae) (Shq1) [NM_181590] 3.9 100609868 100610936 100608716 100610547 
Siglec5 
sialic acid–binding Ig-like lectin 5 (Siglec5) 
[NM_145581] 
3 50621866 50622457 50609751 50611451 
Sirt2 
sirtuin 2 (silent mating type information regulation 2, 
homolog) 2 (S. cerevisiae) (Sirt2),   [NM_022432] 
135.1 29543299 29545476 29540142 29548742 
Slc10a7 
solute carrier family 10 (sodium/bile acid 
cotransporter family), member 7 (Slc10a7) 
[NM_029736] 
11.9 81060535 81061305 81096516 81099222 
Slc19a3 
solute carrier family 19 (sodium/hydrogen 
exchanger), member 3 (Slc19a3) [NM_030556] 
2.8 83056503 83057360 83041309 83042570 
Slc22a1 
solute carrier family 22 (organic cation transporter), 
member 1 (Slc22a1) [NM_009202] 
2.3 12848036 12849292 12877696 12882929 
Slc22a3 
solute carrier family 22 (organic cation transporter), 
member 3 (Slc22a3) [NM_011395] 
2.2 12695672 12696448 12699149 12702277 
Slc35f1 
solute carrier family 35, member F1 (Slc35f1) 
[NM_178675] 
3.9 52471777 52472601 52409777 52411965 
Slc36a3 
solute carrier family 36 (proton/amino acid 
symporter), member 3 (Slc36a3) [NM_172258] 
2.2 54964093 54965918 54970483 54972033 
Slc37a3 
solute carrier family 37 (glycerol-3-phosphate 
transporter), member 3 (Slc37a3) [NM_028123] 
5.1 39285267 39286072 39283955 39286146 
Slc38a1 
solute carrier family 38, member 1 (Slc38a1),   
[NM_134086] 
51.1 96440511 96442054 96470972 96474286 
Slc6a12 
solute carrier family 6 (neurotransmitter transporter, 
betaine/GABA), member 12 (Slc6a12) [NM_133661] 
32 121310087 121312397 121301439 121304278 
Slc9a2 
solute carrier family 9 (sodium/hydrogen exchanger), 
member 2 
26.1 40751088 40751884 40737107 40740105 
Slco2b1 
solute carrier organic anion transporter family, 
member 2b1 (Slco2b1),   [NM_175316] 
7.3 106855450 106858249 106852796 106862898 
Slco3a1 
solute carrier organic anion transporter family, 
member 3a1 (Slco3a1),   [NM_023908] 
2.4 81684280 81684984 81651701 81653290 
Slit2 slit homolog 2 (Drosophila) (Slit2) [NM_178804] 4 48366533 48367568 48373568 48378181 
Slit3 slit homolog 3 (Drosophila) (Slit3) [NM_011412] 3.4 34892566 34893227 34933920 34938027 
Smad1 MAD homolog 1 (Drosophila) (Smad1) [NM_008539] 7.2 81987486 81988513 82016385 82018522 
Smtnl1 smoothelin-like 1 (Smtnl1) [NM_024230] 15.2 84662732 84663871 84661047 84663518 
Smyd3 
SET and MYND domain containing 3 (Smyd3) 
[NM_027188] 
2.7 181416681 181417373 181198865 181200135 
Sncaip 
synuclein, alpha interacting protein (synphilin) 
(Sncaip),   [NM_026408] 
2.5 52965891 52966575 53028063 53029154 
Snrnp48 
small nuclear ribonucleoprotein 48 (U11/U12) 
(Snrnp48) [NM_026382] 
8.5 38311070 38311759 38352282 38354233 
Snrpa1 
small nuclear ribonucleoprotein polypeptide A' 
(Snrpa1) [NM_021336] 
24.3 73146057 73146648 73177283 73182587 
Sord sorbitol dehydrogenase (Sord) [NM_146126] 3.1 122086937 122088462 122080826 122082442 
Sox7 SRY (sex determining region Y)-box 7 2.3 64575692 64577256 64566170 64568324 
Spn sialophorin (Spn),   [NM_009259] 176.8 134295696 134296324 134277437 134282166 
Srebf2 sterol regulatory element-binding factor 2 9.7 82000082 82001007 81970314 81972423 
Srp9 signal recognition particle 9 7.8 184057482 184058385 184028287 184031102 
Srpk2 
serine/arginine-rich protein specific kinase 2 (Srpk2) 
[NM_009274] 
3.3 23193594 23194284 23197396 23198313 
Srrm4 
serine/arginine repetitive matrix 4 (Srrm4) 
[NM_026886] 
3.1 117030794 117032320 117040599 117044462 
St3gal5 
ST3 beta-galactoside alpha-2,3-sialyltransferase 5 
(St3gal5),   [NM_011375] 
18.3 71999875 72001146 72030457 72031949 
St7 suppression of tumorigenicity 7 3.5 17631194 17632402 17631278 17632316 
Stbd1 starch-binding domain 1 (Stbd1) [NM_175096] 4.2 93013372 93013966 93013994 93015511 
Stc2 stanniocalcin 2 (Stc2) [NM_011491] 73 31313202 31314557 31259329 31261702 
Steap3 STEAP family member 3 238 122190287 122191124 122183513 122185343 
Stk35 serine/threonine kinase 35 (Stk35),   [NM_183262] 4.9 129685713 129686506 129654009 129657780 
Stmn2 stathmin-like 2 (Stmn2) [NM_025285] 2.6 8510031 8511800 8509904 8512007 
Stmn4 stathmin-like 4 (Stmn4) [NM_019675] 8.3 67032419 67033089 66962049 66964796 
Stox2 storkhead box 2 (Stox2),   [NM_175162] 11.8 48441583 48442320 48433051 48435200 
Stx17 syntaxin 17 (Stx17) [NM_026343] 4.7 48153216 48153788 48114122 48115740 
Sub1 SUB1 homolog (S. cerevisiae) (Sub1) [NM_011294] 2 11985035 11985867 11968636 11970295 
Suclg1 
succinate-CoA ligase, GDP-forming, alpha subunit 
(Suclg1), nuclear gene encoding mitochondrial 
protein [NM_019879] 
10 73228996 73230031 73221259 73223123 
Sulf1 sulfatase 1 (Sulf1),   [NM_172294] 2.8 12808021 12808857 12825256 12826913 
Sulf2 sulfatase 2 (Sulf2),   [NM_028072] 2.2 165917316 165919880 165973962 165978031 
Svep1 
sushi, von Willebrand factor type A, EGF and 
pentraxin domain containing 1 (Svep1) [NM_022814] 
9.4 58206952 58207823 58218052 58220273 
Svil supervillin 4 4944264 4945633 4944345 4945694 
Synpo2 synaptopodin 2 138.8 122867058 122867794 122885450 122886646 
Syt3 synaptotagmin III (Syt3),   [NM_016663] 2.3 51625271 51626234 51605281 51617079 
Tac1 tachykinin 1 (Tac1) [NM_009311] 2 7503807 7505601 7503957 7507059 
Tbc1d2 
TBC1 domain family, member 2 (Tbc1d2) 
[NM_198664] 
126.4 46693161 46694221 46654111 46659735 
Tbc1d21 TBC1 domain family, member 21 7.4 58198675 58199823 58226243 58227483 
Tbc1d4 
TBC1 domain family, member 4 (Tbc1d4) 
[NM_001081278] 
3.3 101971461 101972283 101912381 101913466 
Tbx15 T-box 15 (Tbx15) [NM_009323] 2.6 99100098 99101303 99042053 99047264 
Tdrd7 tudor domain containing 7 (Tdrd7) [NM_146142] 2.8 45990976 45991755 45976944 45978797 
Tlx1 T-cell leukemia, homeobox 1 (Tlx1) [NM_021901] 4.3 45208155 45208799 45214300 45223545 
Tmem119 
transmembrane protein 119 (Tmem119) 
[NM_146162] 
3.7 114256923 114258622 114262610 114267333 
Tmem132b 
transmembrane protein 132B (Tmem132b) 
[NM_001190352] 
241.2 126052235 126053318 126267198 126268640 
Tmem132c 
transmembrane protein 132C (Tmem132c) 
[NM_175432] 
18.4 127665627 127666494 127720669 127725331 
Tmem2 transmembrane protein 2 (Tmem2),   [NM_031997] 2.2 21881677 21882472 21890257 21891340 
Tmod1 tropomodulin 1 2.7 46036680 46037538 46051482 46057425 
Tmod2 tropomodulin 2 (Tmod2),   [NM_001038710] 3.3 75445942 75446695 75457886 75459846 
Tnks 
tankyrase, TRF1-interacting ankyrin-related ADP-
ribose polymerase 
23.6 36106211 36106877 36174080 36175636 
Tox3 
TOX high mobility group box family member 3 (Tox3) 
[NM_172913] 
100.1 92824093 92824894 92870137 92873228 
Traf3 
TNF receptor-associated factor 3 (Traf3),   
[NM_011632] 
2.3 112408784 112409386 112397726 112401303 
Trak1 trafficking protein, kinesin binding 1 2.2 121198097 121199100 121200754 121205400 
Trappc9 trafficking protein particle complex 9 2 72853465 72856144 72881432 72885933 
Trdn triadin (Trdn) [NM_029726] 8.1 32791136 32791832 33059512 33060737 
Treml1 
triggering receptor expressed on myeloid cells-like 1 
(Treml1) [NM_027763] 
31.6 48504602 48506848 48504585 48506412 
Trerf1 
transcriptional regulating factor 1 (Trerf1),   
[NM_172622] 
7 47259860 47261139 47303358 47307707 
Trib2 tribbles homolog 2 (Drosophila) (Trib2) [NM_144551] 5.5 15748885 15749533 15821023 15824594 
Trim45 
tripartite motif-containing 45 (Trim45),   
[NM_194343] 
3.8 100687232 100688046 100731680 100732667 
Trim54 tripartite motif-containing 54 (Trim54) [NM_021447] 31.9 31418882 31419870 31418522 31419723 
Trim67 tripartite motif-containing 67 (Trim67) [NM_198632] 25.9 127306430 127308157 127315282 127323249 
Tro trophinin (Tro),   [NM_019548] 4 147088514 147089026 147090537 147092393 
Trp53inp2 
transformation related protein 53 inducible nuclear 
protein 2 (Trp53inp2) [NM_178111] 
4.5 155240600 155241406 155201450 155203740 
Trpc1 
transient receptor potential cation channel, 
subfamily C, member 1 
3.2 95600582 95601311 95649515 95651198 
Trpc7 
transient receptor potential cation channel, 
subfamily C, member 7 (Trpc7) [NM_012035] 
4.5 56951110 56952192 56906011 56909110 
Tshz1 
teashirt zinc finger family member 1 (Tshz1) 
[NM_001081300] 
4 84246540 84247476 84220230 84222053 
Tshz2 
teashirt zinc finger family member 2 (Tshz2) 
[NM_080455] 
9.8 169498981 169499691 169457535 169460201 
Tshz3 
teashirt zinc finger family member 3 (Tshz3) 
[NM_172298] 
2.2 37492733 37493765 37492700 37493939 
Tspan3 tetraspanin 3 (Tspan3) [NM_019793] 10.7 55989486 55990071 56038884 56041411 
Tspan8 tetraspanin 8 (Tspan8),   [NM_146010] 4.2 115221521 115222082 115216920 115218216 
Ttc30a1 
tetratricopeptide repeat domain 30A1 (Ttc30a1) 
[NM_030188] 
2.2 75871508 75872120 75834579 75836837 
Ttc32 
tetratricopeptide repeat domain 32 (Ttc32) 
[NM_029321] 
12.4 9106720 9107553 9056130 9062166 
Ttc4 
tetratricopeptide repeat domain 4 (Ttc4),   
[NM_028209] 
10 106366049 106368582 106354054 106355526 
Ttc7b tetratricopeptide repeat domain 7B (Ttc7b) 4.1 101736979 101738322 101716041 101721532 
[NM_001033213] 
Ttll7 
tubulin tyrosine ligase–like family, member 7 (Ttll7) 
[NM_027594] 
198.2 146531589 146532187 146578616 146580183 
Ttn titin (Ttn), transcript variant N2-A [NM_011652] 4 76744022 76744755 76807198 76808538 
Txndc5 
thioredoxin domain containing 5 (Txndc5) 
[NM_145367] 
35.5 38641619 38642258 38629125 38630624 
Uggt1 
UDP-glucose glycoprotein glucosyltransferase 1 
(Uggt1) [NM_198899] 
3.7 36225320 36226045 36309499 36313520 
Uhrf1bp1 
UHRF1 (ICBP90) binding protein 1 (Uhrf1bp1) 
[NM_001080769] 
5.8 27987660 27988398 28011158 28014939 
Umps 
uridine monophosphate synthetase (Umps) 
[NM_009471] 
3.2 33983532 33984301 33997189 33999783 
Unc13a 
unc-13 homolog A (C. elegans) (Unc13a) 
[NM_001029873] 
2.1 74168143 74169168 74167888 74171172 
Unc5cl 
unc-5 homolog C (C. elegans)-like (Unc5cl) 
[NM_152823] 
58.7 48651810 48652769 48598587 48600491 
Unc79 
unc-79 homolog (C. elegans) (Unc79) 
[NM_001081017] 
2.6 104162021 104162789 104186398 104188535 
Upb1 ureidopropionase, beta (Upb1) [NM_133995] 28.9 74837900 74838632 74868760 74870452 
Use1 
unconventional SNARE in the ER 1 homolog (S. 
cerevisiae) (Use1),   [NM_025917] 
3.9 73871114 73872627 73877141 73886026 
Usp29 ubiquitin-specific peptidase 29 4.5 6880296 6881101 6870470 6872648 
Usp30 ubiquitin-specific peptidase 30 2.3 114560601 114563452 114554403 114558599 
Usp42 
ubiquitin-specific peptidase 42 (Usp42) 
[NM_029749] 
3.9 144444285 144445384 144475226 144479456 
Utp14b 
UTP14, U3 small nucleolar ribonucleoprotein, 
homolog B (yeast) (Utp14b),   [NM_001001981] 
2.1 78712488 78713419 78712558 78713452 
Vat1l 
vesicle amine transport protein 1 homolog-like (T. 
californica) (Vat1l) [NM_173016] 
24.7 116729100 116731018 116728608 116731255 
Vdac3 
voltage-dependent anion channel 3 (Vdac3),   
[NM_011696] 
4 23675708 23676755 23678215 23681120 
Vldlr 
very low density lipoprotein receptor (Vldlr),   
[NM_013703] 
2.8 27215041 27216127 27312294 27313639 
Vti1a 
vesicle transport through interaction with t-SNAREs 
1A 
5.8 55408847 55409876 55416100 55417693 
Wbscr17 
Williams-Beuren syndrome chromosome region 17 
homolog (human) (Wbscr17) [NM_145218] 
4.7 131871425 131872703 131780787 131784325 
Wfdc3 
WAP four-disulfide core domain 3 (Wfdc3) 
[NM_027961] 
2.5 164567002 164567866 164558960 164561160 
Wisp2 
WNT1 inducible signaling pathway protein 2 (Wisp2) 
[NM_016873] 
18.4 163612515 163613513 163647668 163651653 
Wnt5a 
wingless-related MMTV integration site 5A (Wnt5a),   
[NM_009524] 
4.9 29264113 29264727 29255334 29256884 
Xpo7 exportin 7 (Xpo7) [NM_023045] 88 71197033 71198684 71173775 71178601 
Xrcc6bp1 
XRCC6-binding protein 1 (Xrcc6bp1),   
[NM_001159559] 
4.3 126335254 126336170 126326079 126328066 
Zbp1 Z-DNA–binding protein 1 (Zbp1),   [NM_021394] 118.6 173041305 173043285 173041109 173045625 
Zeb2 
zinc finger E-box–binding homeobox 2 (Zeb2),   
[NM_015753] 
204.2 45053779 45054366 44970656 44973294 
Zfp2 zinc finger protein 2 (Zfp2),   [NM_001044697] 13.6 50723506 50724487 50719465 50720284 
Zfp238 zinc finger protein 238 (Zfp238),   [NM_013915] 3.6 179392853 179394131 179386281 179387524 
Zfp369 zinc finger protein 369 (Zfp369) [NM_178364] 3.5 65411046 65411799 65410953 65412030 
Zfp383 zinc finger protein 383 (Zfp383) [NM_001243908] 2.4 30660328 30661118 30648892 30651109 
Zfp518b 
zinc finger protein 518B (Zfp518b),   
[NM_001081144] 
10.8 39060488 39060964 39064339 39066045 
Zfp521 zinc finger protein 521 (Zfp521) [NM_145492] 10.7 14075720 14076433 14127886 14130415 
Zfp607 zinc finger protein 607 (Zfp607) [NM_001024726] 4 28661198 28661989 28655938 28657550 
Zfp92 zinc finger protein 92 (Zfp92) [NM_009566] 2.6 70666932 70668380 70666768 70668613 
Zfr zinc finger RNA-binding protein (Zfr) [NM_011767] 5.3 12065977 12066576 12004279 12005874 
0610011L14Rik 
RIKEN cDNA 0610011L14 gene (0610011L14Rik),   
[NM_026661] 
28.5 156383285 156384943 156366470 156369464 
0610040J01Rik 
RIKEN cDNA 0610040J01 gene (0610040J01Rik) 
[NM_029554] 
508 64159275 64160226 64202895 64204576 
1110004F10Rik 
RIKEN cDNA 1110004F10 gene (1110004F10Rik) 
[NM_019772] 
172.2 123290936 123292664 123262748 123264502 
1110032A03Rik RIKEN cDNA 1110032A03 gene 6.8 50600617 50601198 50610935 50612362 
1110038F14Rik 
RIKEN cDNA 1110038F14 gene (1110038F14Rik) 
[NM_054099] 
2.1 76765559 76766318 76762933 76766429 
1300010F03Rik 
RIKEN cDNA 1300010F03 gene (1300010F03Rik),   
[NM_173758] 
8.9 79324915 79325579 79432547 79433615 
1700001L19Rik 
RIKEN cDNA 1700001L19 gene (1700001L19Rik) 
[NM_027035] 
99.6 68753198 68753801 68751127 68752127 
1700008A04Rik 
RIKEN cDNA 1700008A04 gene (1700008A04Rik) 
[NM_027050] 
2.4 32710972 32711814 32732218 32733874 
1700011L22Rik 
RIKEN cDNA 1700011L22 gene (1700011L22Rik) 
[NM_026315] 
3 81739495 81739976 81711757 81714862 
1700056E22Rik RIKEN cDNA 1700056E22 gene (1700056E22Rik) 3.2 185926501 185926968 186017045 186018960 
Genes up-regulated in Cbx4KO cells and showing Cbx4 and H3K27me3 binding. Directly overlapping Cbx4 and 
H3K27me3 ChIP-seq peaks are shown in red. 
[NM_028516] 
2310046A06Rik 
RIKEN cDNA 2310046A06 gene (2310046A06Rik) 
[NM_027150] 
137.1 77204923 77205753 77232795 77234161 
2410076I21Rik 
RIKEN cDNA 2410076I21 gene (2410076I21Rik) 
[NM_028598] 
14.4 58600384 58601025 58600080 58601330 
2700060E02Rik 
RIKEN cDNA 2700060E02 gene (2700060E02Rik) 
[NM_026528] 
3.2 20709016 20709954 20615795 20617035 
4930403N07Rik 
RIKEN cDNA 4930403N07 gene (4930403N07Rik) 
[NM_028687] 
2.8 73261933 73262571 73298819 73299961 
6720456H20Rik 
RIKEN cDNA 6720456H20 gene (6720456H20Rik) 
[NM_172600] 
22.2 49157918 49158600 49047830 49049540 
9530059O14Rik RIKEN cDNA 9530059O14 gene 2.1 122490155 122490785 122477125 122482835 
9930013L23Rik 
RIKEN cDNA 9930013L23 gene (9930013L23Rik) 
[NM_030728] 
2.5 91247980 91248809 91233194 91237271 
A530098C11Rik 
RIKEN cDNA A530098C11 gene (A530098C11Rik) 
[NM_001013799] 
13.4 44091624 44092993 44091544 44092592 
A730011L01Rik 
RIKEN cDNA A730011L01 gene (A730011L01Rik),   
[NM_177394] 
4.5 119340744 119341974 119322649 119324480 
A830080D01Rik 
RIKEN cDNA A830080D01 gene (A830080D01Rik) 
[NM_001033472] 
2.5 155946220 155946946 155964071 155966209 
A930033H14Rik 
RIKEN cDNA A930033H14 gene (A930033H14Rik), 
partial miscRNA [XR_105403] 
2.2 68711154 68711952 68698878 68700651 
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Figure S1. Expression of the PRC1/PRC2 genes and Nefl gene in mouse epidermis during development. (A) Expression of the distinct PRC1 and PRC2 
genes in the laser-captured mouse epidermis during distinct stages of development (Agilent microarray values normalized to the reference RNA levels 
are shown relative to the corresponding expression levels in E11.5 epidermis). The data shown are from a single experiment performed in duplicate. 
(B) Expression of different Cbx genes in the epidermis of E16.5 WT and Cbx4KO mice (Agilent microarray, background-normalized data). The data shown 
are from a single experiment performed in duplicate (mean ± SD). n = 2; two-way t test. (C) Expression of the Nefl transcripts in WT mouse epidermis at 
distinct stages of development (Agilent microarray values normalized to the reference RNA levels). The data shown are from a single experiment performed 
in duplicate (mean ± SD; n = 2; one-way ANO VA).
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Figure S2. Characterization of the changes in gene expression in the epidermis of Cbx4KO mice and in primary KCs after Cbx4 knockdown. (A) Immuno-
fluorescence detection of Ring1b shows similar patterns of expression in the epidermis of E16.5 WT and Cbx4KO mice. Bar, 25 µm. (B) Kdm2b transcript 
levels are significantly up-regulated in the E16.5 epidermis of Cbx4KO mice compared with WT controls (mean ± SD; n = 3). (C) Correlated total cell 
fluorescence level of H2AK119ub1 and H3K27me3 show a lack of differences in their expression between the dermal cells of E16.5 WT and Cbx4KO 
mice. (D) Down-regulation of the Cbx4 transcripts in the primary mouse KCs after treatment with Cbx4 shRNA (mean ± SD; n = 3). **, P < 0.01; ***, P 
< 0.001. ns, not significant.
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Figure S3. Analyses of the senescence and apoptotic markers in WT and Cbx4-deficient skin. (A) p16 and p19 transcript levels are significantly up- 
regulated in the epidermis of E16.5 Cbx4KO mice compared with WT controls (mean ± SD; n = 3). (B) Increased Cdkn1c/p57 protein expression in the 
epidermis of E16.5 Cbx4KO mice. Dashed lines separate epidermis and dermis. (C) ChIP-qPCR analyses show an enrichment for Cbx4, H2AK119ub1, 
and H3K27me3 in the promoter region of the Cdkn2a gene in primary KCs (mean ± SD; n = 3). (D) Increase of the levels of the Cdkn2a and Cdkn1c 
transcripts in primary mouse KCs infected with retrovirus expressing a mutant Cbx4 chromodomain (Cbx4CDM; mean ± SD; n = 3). (E) Appearance of 
γ-H2AX–positive cells in the epidermis of E16.5 Cbx4KO mice. Integrin-β4 (Itgb4) expression outlines the basement membrane of the epidermis. DAPI 
counterstain (blue) shows the nuclei. (F) A lack of caspase 3–positive cells in the epidermis of E16.5 WT and Cbx4KO mice. Integrin-β4 expression outlines 
the basement membrane of the epidermis. DAPI counterstain (blue) shows the nuclei. Bars, 50 µm. **, P < 0.01; ***, P < 0.001.
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Figure S4. The analyses of epidermal and Merkel cell differentiation in Cbx4KO and WT mice. (A) Quantification of the ratios between different cellular 
layers expressing distinct markers of epidermal differentiation shows a significant increase of the cellular layers expressing the markers of terminal KC dif-
ferentiation (Loricrin, Involucrin, and Filaggrin) in the epidermis of E16.5 Cbx4KO mice versus WT controls (P < 0.01). (B and C) Immunofluorescence anal-
yses of the Merkel cells expressing K18 (B, arrows) show a lack of differences between the epidermis of E16.5 Cbx4KO and WT mice. Integrin-β4 (Itgb4) 
expression outlines the basement membrane of the epidermis (C). DAPI counterstain (blue) shows the nuclei. Bar, 50 µm. *, P < 0.05. ns, not significant.
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Table S1. Expression of PRC1 and PRC2 genes in epidermal progenitor cells at different stages of epidermal development
















Bmi1 4,939 0.78 890 1.00 1,959 0.32 164.19 0.54
Cbx2 10,576 2.69 2,616 2.64 7,870 1.96 1,062.61 0.40
Cbx4 5,757 0.44 5,378 0.99 8,019 0.60 7,709.26 0.74
Cbx6 26,436 1.18 4,686 1.61 39,345 1.67 196.33 0.57
Cbx7 2,643 1.00 28 0.44 12,494 3.73 369.93 0.60
Cbx8 3,995 2.38 2,623 3.58 1,548 1.03 21,910.41 0.59
Pcgf1 3,271 1.27 114 0.24 4,264 2.26 7,096.51 3.64
Pcgf2 387 1.02 22 1.21 384 0.92 230.91 0.72
Pcgf6 1,816 0.58 354 0.71 1,662 0.49 1,946.37 0.65
Phc1 29,160 1.75 135 0.17 68,436 3.99 10,662.08 1.47
Phf19 1,053 0.56 196 0.83 1,198 0.55 788.60 0.51
Ring1 1,179 1.16 69 0.44 1,831 1.51 728.27 0.59
Rnf2 1,006 0.53 28 0.24 945 0.48 181.02 0.03
Rybp 222 0.53 134 1.27 208 0.50 221.50 0.56
PRC2
Eed 2,095 0.51 91 1.17 1,960 0.44 3,339 0.67
Ezh1 749 1.45 122 2.13 1,672 3.49 3,882 7.89
Ezh2 2,341 0.43 484 1.36 1,098 0.20 671 0.12
Jarid2 8,854 4.31 4,561 2.08 11,294 5.55 304 0.18
Mtf2 6,840 4.10 3,727 1.34 2,968 1.70 1,582 0.71
Mtf2 17,216 3.74 885 1.72 6,605 1.26 2,960 0.67
Rbbp4 28,626 2.36 10,711 2.67 6,897 0.62 4,209 0.34
Rbbp7 36,889 0.59 5,890 0.65 15,775 0.24 9,247 0.12
Suz12 14,478 0.82 2,603 0.92 4,917 0.33 1,909 0.12
Agilent Technologies whole genome microarray values: absolute expression levels (a.u.) and normalized to reference RNA.
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Table S2. Cbx4 target genes up-regulated in p63KO epidermal progenitor cells
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Table S3. Primers used for qRT-PCR analyses
Gene Oligos 5′- to -3′
qRT-PCR primers 
Cbx4 AGT GGAGT ATCTG GTGAA ATGGA
TCC TGCCT TTCCC TGTTC TG
Cdkn2a/p16 ATG GGTCG CAGGT TCTTG GT
ATC ATCAC CTGGT CCAGG ATTCC
Cdkn2d/p19 CCT TGCAG GTCAT GATGT TTGG
CCA GGGCA TTGAC ATCAG CA
En2 CTT CTTCA GGTCC CAGGT
CAA ATCTT GATCT GAGAC TCGT
Flg GAA GGAAC TTCTG GAAGG ACAAC
TCC ATCAG TTCCA CCATG CCTC
Gapdh GTG TTCCT ACCCC CAATG TG
AGG AGACA ACCTG GTCCT CA
Ivl GCA GGAGA AGTAG ATAGAG
TTA AGGAA GTGTG GATGG
Lhx4 CCG ATGCA ACAGA TTCCC
GAA GCATC TGTCA GCCAG
Kdm2b GAT GCTGA GCGGT ATCAT CCG
GAG ACAGC GATCC ATGAG CAG
Mobp CCA GGCTC TCCAA GAACC AG
GGT CCACG ATCTC ACGCTT
Nefl CGC CATGC AGGAC ACAAT CA
GAG TAGCC GCTGG TTATG CT
Neurog3 TCG TCTTT ACTGC CCGCT AC
CTA GGGCT TTCCG GTTCA CA
Olig2 TCC CCAGA ACCCG ATGAT CTT
CGT GGACG AGGAC ACAGTC
Zeb2 ATT GCACA TCAGA CTTTG AGGAA
ATA ATGGC CGTGT CGCTT CG
Cloning primers
Cbx4 enhancer AAT CGATA AGGAT CCTTT GAGAA CAGAA CAAGG GT
AGG GCATC GGTCG ACGGA TTTCA GACAG CCAAGG
ChIP primers
Cbx4 TGT GTCAA AGAGA CTAAG GACAGC
AGC TCCAG TGCTC AGTGG TC
Lor ACC AGCTT ACCAC TCTCC CA
GTC TGGTC TCTCC AGTTG GC
Nefl GTC AGAGT CCCGG CGTAT AA
AGC CGAAC GAACT CATGG TG
Cdkn2a TCG CTCCG GTTAA CTTTC GG
GCC TCGCC GATCT TCCTA TT
Table S2. Cbx4 target genes up-regulated in p63KO epidermal progenitor cells (Continued)
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Table S4. List of antibodies used in this study
Antigen Application Host Dilution Catalog number Supplier
Caspase 3 active IF Rabbit 1:200 ab13847 Abcam
Cbx4 ChIP Rabbit 5 µg A302-355A Bethyl Laboratories, Inc.
Cbx4 IF Rabbit 1:100 This study/polyclonal antibody against amino 
acids 363–551
CD104 (Itgb4) IF Rat 1:100 553745 BD
Cdkn1c IF Rabbit 1:100 ab4058 Abcam
Filaggrin IF Rabbit 1:100 sc-30230 Santa Cruz Biotechnology, Inc.
gH2A.x IF Rabbit 1:100 39117 Active Motif
H2AK119ub1 IF/ChIP Rabbit 1:200 8240s Cell Signaling Technology
H3K27me3 IF/ChIP Rabbit 1:100; 5 µg 39157 Active Motif
Involucrin IF Rabbit 1:100 ab53112 Abcam
Ki67 IF Rabbit 1:100 ab15580 Abcam
Krt10 IF Rabbit 1:100 ab76318 Abcam
Krt14 IF Rabbit 1:100 ab7800 Abcam
Krt18 IF Rabbit 1:100 sc-31700 Santa Cruz Biotechnology, Inc.
Loricrin IF Rabbit 1:1,000 PRB-145P Covance
Nefl IF Rabbit 0.111111 NB300-131 Novus Biologicals
Ring1b IF Rabbit 1:100 5694P Cell Signaling Technology
IF, immunofluorescence.
Table S5 is supplied as a PDF and it shows Cbx4 target genes in epidermal KCs.
